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Abstract 
ELE CT ROP HYS IO LOG ICAL EFFE CTS OF L YSOP LASMENYL CHOLINE ON 
RABBIT VENTRI CU LA R M YO CYTES 
Ray Andrew Caldwell, BS 
A thesis submitted in partial jitljillment of the requirements for the degree of Doctor of 
Philosophy at the Medical College of Virginia, Virginia Commonwealth University. 
Virginia Commonwealth Uni versity, 1 997 
Advisor: Cli ve Marc Baumgarten , Ph.D. 
Professor 
Department of Physiology 
Myocardial ischemia acti vates a phospholipase A2 that targets plasmalogen 
phospholipids and liberates l -O-alkenyl-lysoplasmenylcholine (LPL C) in preference to 1 -0-
acyl-lysophosphatidylcholine (LP C). A lthough LP C is a pro arrhythmic ischemic metabolite, 
the effect of LP LC on cardiac electrophysiology is unknown. At the lowest doses 
in vestigated, LPL C  induced spontaneous contractions in otherwise quiescent rabbit 
ventricular myocytes significantly faster than LP C. Spontaneous contract ions de ve loped 
with median times of 1 6.4 (n = 64), 27.4 (n = 36), and >60 min (n = 25) during exposure to 
5, 2.5, and 1 Io!M LPL C compared with 38.0 (n = 48) and >60 min (n = 29) for 5 and 2.5 Io!M 
LP C, respecti vely. Median times for 1 0  Io!M lysolipids were not di fferent. To characterize 
the mechanism of spontaneous acti vity, membrane potential (Em) and whole-cell currents 
xiii 
were measu red. LPL C caused an abrupt and sustained depolarization of Em by <: 50 m V and 
culminated in the loss of e xcitability (n = 7). Voltage-clamp analysis of steady-state currents 
re vealed an inward c urrent at the no rmal resting E m  that re ve rsed at - 18.5 ± 0.9 mV (n = 12).  
The re ve rsal potential of this cu rrent was insensitive to Ca-cha nnel b lockade by Cd2+ (n = 3), 
o r  by lowe ring bath [Cl l Howe ve r, a l O-fold reduction in bath [Na+ ] caused repo larization 
and reduced the inwa rd current by 56.6 ± 3 .6% at -83 m V (n = 4). In cont rast , Na-channel 
blockade by tetrodoto xin (n = 4) o r  saxito xin (n =3) failed to i nhibit memb rane 
depo la rization o r  the current induced by LPL C. Two la nthanides we re studied to dete rmine 
if the LPL C c urrent was mediated by st retch-acti vated channe ls (SA Cs). Gd3+ ( 100 11M), a 
known SAC b locker, and La3+ (1 00 11M), de void of SAC blocking acti vity , inhibited the 
LPLC-induced c urrent by 80.2 ± 8.3% (n = 7) a nd 80.7 ± 8.3 % (n = 6), respecti vely , at -83 
m V. E xposure to hypertonic bathing medium and cell sh ri nkage failed to resto re E m  (n = 5) 
o r  i nhibit the LPL C-induced cu rrent (n = 2), which confirmed that lanthanides we re not 
acting th rough i nhibition of  SACs. Consistent with the effects on memb rane current , 
p retreatment with 100 11M Gd3+ o r  La3+ but not Cd2+ , significantly delayed spontaneous 
acti vity in 5 11M LPLC (media n times: Gd3+ , 55.4 min (n = 35); La3+ , 53.0 min (n = 38); Cd2 +, 
17.4 m in en = 19)). Lanthanides increase phospholipid ordering and may oppose membrane 
perturbations induced by LP LC. LP LC may co nt ribute to vent ricular dys rhythmias d uring 
ischemia. 
Chapter 1 - Introduction 
Individuals who experience sudden, unexpected cardiac arrest within one hour from 
the onset of symptoms account for one-half of the more than 600 ,000 people who die 
annually from coronary heart disease in the U.S. (Kannel and Thomas, 1982). Although 
sudden cardiac death has many causes, it is primarily attributed to ischemia-induced 
arrhythmias caused by atherosclerosis (Kannel and Thomas, 1982; Laskey, 1993; Roberts, 
1993). While the reduction in mortality from coronary heart disease over the last decade has 
been encouraging, the number of cardiovascular sudden deaths has remained unchanged 
(Laskey, 1993). 
Electrophysiological Alterations During Acute Myocardial Ischemia. 
Electrophysiological studies at the tissue and whole animal level have been useful 
in identifying some of the earliest manifestations of myocardial ischemia. Within minutes 
following cessation of coronary flow, alterations in both passive and active cardiac electrical 
properties are observed. There is a gradual depolarization of the resting membrane potential. 
Subsequently, there is a reduction in the amplitude and duration of the ventricular action 
potential and a decrease in the maximum rate of rise of the action potential upstroke, dV /dt, 
(Downar, Janse and Durrer, 1977; Gettes and Cascio, 1992). Effects on excitability and 
2 
refractoriness are biphasic. Initially, excitability is increased and the refractory period is 
shortened even though a slight depolarization of the resting membrane potential occurs 
(Gettes and Cascio, 1992). Longer durations of ischemia cause further depolarization of the 
resting potential concomitant with a reduction in excitability and prolonged refractoriness 
(post-repolarization refractoriness). This complex interplay of the time-dependent changes 
in cardiac electrophysiological properties during ischemia have been attributed, at least in 
part, to alterations in ionic conductances and changes in both intra- and extracellular ionic 
milieus (Gettes and Cascio, 1992). 
One of the earliest ionic disturbances following myocardial ischemia is a rapid 
increase in extracellular K+. The elevation of extracellular K+ causes depolarization of the 
resting membrane potential with subsequent effects on excitability, action potential dV/dt, 
and amplitude. The rise in extracellular K+ during ischemia is attributed to an increased 
myocardial K+ efflux, and several mechanisms have been suggested. It has been argued that 
the major K+ efflux results from electroneutral coefflux with lactate and phosphate anions 
(Weiss, Lamp and Shine, 1989; Gettes and Cascio, 1992). Also, there is evidence to suggest 
that ATP-sensitive K-channels (KATP) contribute to the extracellular K+ accumulation, since 
inhibition of these channels by sulfonylureas limits the increased extracellular K+ 
accumulation during ischemia. However, the contribution of KATP channels to the 
extracellular K+ rise during the acute ischemic phase has been disputed. Arguments against 
involvement of KATP channels are based on the disparity in the rapid time course of 
3 
extracellular K+ accumulation and the much slower fall in ATP to concentrations sufficient 
to activate approximately 50% ofKATP -channels (i.e., an ATP concentration of 17 -\ 00 JlM; 
Nichols and Lederer, 199 1). Because of the large KATP-channel conductance and high 
channel density, activation of only a small fraction ofKATP-channels is sufficient to support 
a substantial K+ efflux. Opening of as little as 1 % of all KATP channels is predicted to affect 
the resting membrane potential and regulate insulin secretion in pancreatic p-cells (Cook, 
Satin, Ashford, and Hales, 1988). Activation of the same fraction of KATP-channels in 
ventricular myocardium is predicted to shorten action potential duration by up to 50% 
(Nichols and Lederer, 1991). Thus, a small reduction in ATP levels is adequate to open a 
sufficient number ofKATP-channeis in heart to contribute to both the K+ efflux and action 
potential shortening observed during myocardial ischemia. 
Another mechanism for regulating K+ efflux during ischemia involves phospholipid 
signaling. Arachidonate, a free-fatty acid released by phospholipase A2 (PLA2)-dependent 
catabolism of membrane phospholipids, accelerates the kinetics of activation and inactivation 
of the human K-channel, Kvl. l  (Gubitosi-Klug, Yu, Choi and Gross, 1995). Both 
arachidonate and acidic pH have been shown to activate a K+ conductance in rat heart 
(Wallert, Ackerman, Kim and Clapham, 1991). Intracellular acidosis and the liberation of 
arachidonate from membrane phospholipids occur during myocardial ischemia (Miyazaki, 
Gross, Sobel and Saffitz, 1990; Gettes and Cascio, 1992; Hazen and Gross, 1992) and 
modulate K-channels. K+ efflux is likely to be an important mediator of the 
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electrophysiological sequella during myocardial ischemia and could lead to depolarization 
of the resting membrane potential , shortening of action potential duration, reduced dV /dt, 
s lowed conduction, and inexcitability. These electrophysiological alterations contribute to 
the formation of reentrant ventricular arrhythmias (Janse, 1992), most commonly associated 
with myocardial ischemia (Pogwizd and Corr, 1987). However, quantitation of the 
contribution of different K-channel isoforms to the rise in extracellular K+ and alterations in 
the ventricular action potential observed during the acute ischemic phase must await the 
development of selective antagonists. 
The biochemical and electrophysiological manifestations of myocardial ischemia 
have been areas of intense research interest for the last 30 years. The goal of this research 
usually has been to elucidate the arrhythmogenic mediator produced by myocardial ischemia. 
Since the locus of e lectrical activity in hear t is confined to the sarco lemma, much attention 
has focused on membrane alterations dur ing myocardial ischemia. Indeed, one of the earliest 
biochemical manifestations of myocardial ischemia is accelerated p hospholipid catabolism 
resulting in the accumulation of lysophospholipids in cardiac tissue ( Corr, Yamada, Creer, 
Sharma, and Sobel, 1 987; Corr, Creer, Yamada, Saffitz, and Sobel, 1989; Sedlis, Hom, 
Sequeira, and Espos ito, 1993) a nd coro nary ve nous e fflue nts (S nyder , Crafford Jr. ,  Clashow, 
Rankin, Sobel, and Corr, 1 98 1 ;  Sedlis, Sequeira, and Altszuler , 1 990). Lysolipid 
accumulation in ischemic myocardium temporally parallels the onset of arrhythmias ( Corr 
et al., 1 987). Exogenous application of Iysolipids to Purkinje fibers or ventricular tissue 
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mimics the electrophysiological alterations of the action potential waveform seen in vivo 
during myocardial ischemia (Gross, Corr, Lee, Saffitz, Crafford, and Sobel, 1982). While 
the pathophysiology of myocardial ischemia is complex and multifactoral (Gettes and 
Cascio, 1992), lysolipids are believed to be an important contributor to the induction of 
arrhythmias during ischemia (Corr, McHowat, Yan and Yamada, 1995). 
Lysophosphatidylcholine (LPC) is a product of diacyl phospholipid catabolism (see 
page 19). LPC is an established proarrhythmic ischemic metabolite that has been studied 
extensively over the years (Corr et al., 1995). In addition to having effects on the cardiac 
action potential, LPC has been shown to inhibit cardiac voltage-dependent- Ca- (Clarkson 
and Ten Eick, 1983), K- (Clarkson and Ten Eick, 1983; Kiyosue and Arita, 1986) and Na­
currents (Sato, Kiyosue, and Arita, 1992; Shander, Undrovinas, and Makielski, 1996); to 
promote bursting of unitary Na-channels at depolarized (Burnashev, Undrovinas, Fleidervish, 
and Rosenshtraukh, 1989; Burnashev, Undrovinas, Fleidervish, Makielski, and 
Rosenshtraukh, 1991; Undrovinas, Fleidervish, and Makielski, 1992) and at subthreshold 
potentials (Undrovinas et aI. , 1992); and to induce a non-selective cationic current (Liu, 
Goldhaber, and Weiss, 1991; Magishi, Kimura, Kubo, and Abiko, 1996). 
Long-chain acylcarnitines (LCACs) are structural analogs of LPC and also 
accumulate in ischemic myocardium (Corr et al. , 1989). LCACs inhibit cardiac Ca- (Wu and 
Corr, 1992), Na- (Sato et al., 1992), and gap junction-conductance (Wu, McHowat, Saffitz, 
Yamada, and Corr, 1993). In addition, because of their structural similarity to LPC, LCACs 
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inhibit enzymes responsible for LPC catabolism (Corr et al., 1995). Thus, accumulation of 
LCACs during myocardial ischemia is expected to directly inhibit voltage-dependent ion 
channels and secondarily, augment LPC accumulation in ischemic myocardium due to 
inhibitory effects on enzymes which catabolize LPC. 
Table 1 is a selected list characterizing the effects of lysolipids and LCACs on 
cardiac ion channels, exchangers and transporters. Because of the multiple of effects 
described, it has been argued that lysolipids act by inducing nonspecific alterations in 
membrane biophysical properties (Weltzien, 1979; O'Regan, Alix, and Woodbury, 1996). 
Indeed, lysolipids increase membrane fluidity of both model (Han and Gross, 1991) and 
biological cell membranes (Fink and Gross, 1984). Since the function of integral membrane 
proteins depends on their annular lipid environment (Brenner, 1984; Hermoni-Levine and 
Rahamimoff, 1990; Ford and Hale, 1996), local changes in the lipid milieu caused by 
incorporation of lysolipids could affect protein function. At higher concentrations, lysolipids 
form micelles having detergent like-properties. Micelles solubilize membrane proteins and 
destroy the membrane permeability barrier (Weltzien, 1979; Katz, 1992). Thus, the effects 
characterized in Table 1 using high concentrations of lysolipids cannot unambiguously be 
ascribed to a direct interaction of monomeric lysolipid with the cell membrane or integral 
proteins. 
Table 1. Effects of Iysolipids and LCAC on cardiac electrophysiological processes 1 . 
Amphiphile Concent. 
(!-1M) 
A. IK 
LPC 20-200 
LPC 20- 100 
B. INa 
LPC 5-50 
LPC 1 0  
LPC 20 
LCAC 0.5-50 
Process 
I gK 
I YK1 
Reference 
Clarkson and Ten Eick, 1983 
Kiyosue and Arita, 1986 
I gNa' delayed kinetics of Sato, Kiyosue, and Arita, 1992 
activation and inactivation 
IgNa, delayed kinetics of in- Shander et al., 1996 
activation, hyperpolarizing shift 
h�, r Tree 
I Po, bursting, hyperpolarizing Burnashev etal. , 1989; Burnashev 
shift m� et al., 1991 ;  Undrovinas et a/., 
1992. 
I gNa' delayed kinetics of Sato, Kiyosue, and Arita, 1992 
activation and inactivation 
-contin ued-
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Table 1. -continued-
Amphiphile Concent. Process Reference 
(�M) 
C.lca 
LPC 20-200 I gCa Clarkson and Ten Eick, 1983 
LCAC 1 -25 I gCa ' depolarizing shift d� and Wu and Corr, 1992 
t 
LPLC 5 I gCa Alvermann, Ford, Friedrich, Gross, 
Han, Hirche, Zupan, and Benndorf, 
1992 
D. Icat-ns 
LPC 5-40 Liu, Goldhaber, and Weiss, 1991 
LPC 1 0  Magishi, Kimura, Kubo, and Abiko, 
1 996 
E. Igap 
LCAC 5 Wu, McHowat, Saffitz, Yamada, 
and Corr, 1993 
-continued-
Table 1 .  -continued-
Amphiphile Concent. 
(!-1M) 
F. Na+-Ca2+-exchange 
LPC 3!-1mol/mg prot. 
G. IT; 
LCAC 1 0  
H .  Na+-K+-ATPase 
LPC 750 
LPC 1 0-30 
LCAC 25-160 
Process Reference 
Bersohn, Phillipson, and Weiss, 
1991 
Wu and Carr, 1994 
Owens, Kennett, and Weglicki, 
1 982 
Karli, Karikas, Hatzipavlov, and 
Levis, 1979 
Wood, Bush, Pitts, and Schwartz, 
1977 
9 
1LPC, Iysophosphatidylcholine; LCAC, long-chain acylcarnitine; LPLC,lysoplasmenylcholine; Ix (where X = K, Na, Ca), 
macrosopic current; gx (X = K, Na, Ca), macroscopic conductance; YK1' unitary inwardly rectifying potassium current; 
h�, steady-state Na-channel availability; m�, steady-state Na-channel fractional activation; d�, steady-state Ca-channel 
availability; t. steady-state Ca-channel fractional activation ;  Trec' time constant for recovery from Na-channel 
inactivation; Po, open channel probability; leat.ns, macroscopic nonselective cationic current; Igap, gap junctional current; 
In, transient inward current. 
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Subclassification of Membrane Phospholipids-Plasmalogens. 
Although multiple studies have described the cardiac electrophysio logical effects of 
LPC, this amp hiphile is only one of se veral lysolipids produced during myocardial ischemia 
(Man, Slater, Pelletier and Choy, 1983; Steenbergen and Jennings, 1984; Davies, Schul z, 
Olley, Strynadka, Panas, and Lopaschuk, 1992). In fact, LPC is deri ved from diacyl 
phospholipid, the minor subclass of sarcolemmal phospholipids in some species (Gross, 
1984). Cardiac and other electrically excitable tissue are selecti vely e miched with 
plasmalogen phospholipids. Figure I shows the structure of plasmeny 1choline, a 
p lasmalogen phospholipid, and the more commonly recogni zed structure of 
phosphatidy1choline, a diacyl phospholipid. Plasmalogen phospholipids are readily 
distinguished from their diacyl counte rparts by the vinyl-ether sn-l linked fatty acid 
(compare dashed lines). The alkenyl moiety of plasma log ens confers structural rigidity to 
the phospholipid and affects membrane packing. The vinyl-ether linkage also pro vides 
plasmalogens with unique interfacial properties and may explain why plasmalogens exhibit 
differences in membrane molecular dynamics and are more susceptible to attack by PLA2 as 
compared with their diacyl counterparts (see below). 
The disco very o f  plasmalogens in 1924 by Feulgen and Voit occurred serendipitously 
while they were working with Nyctotherus proto zoa (Debuch and Seng, 1972). Although 
Feulgen was noted at the time for his nuclear staining technique, a laboratory error resulted 
in localization of the nuclear stain to the cell "plasma " .  After realizing his mistake, F eulgen 
Phosphatidylcholine Plasmenylcholine 
+ + 
0- (CH, ),N(CH3h 
I _ 
0- (CH, ),N(CH3h 
I 
0= p-o 
I 
CH, -CH - CH,-O 
I I 
o 0 
I I 
C=OC=O 
I I (CH,), (CH')J 
I I 
CH3 CH3 
0= p-o-
I 
CH, -CH - CH,-O 
I I 
0 0 
I I 
CH C=O 
II I 
CH (CH')J 
I I 
(CH,), CH3 
I 
CH3 
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Figure 1. Cardiac choline phospholipid subclasses. Plasmalogens are a distinctive 
yet selectively enriched subclass of phospholipids in cardiac cell membranes. They 
are distinguished from their more commonly recognized diacyl counterparts (Le.,  
phosphatidylcholine) by having an sn-1 oxygen-ether linkage rather than an acyl­
ester attachment (compare structures enclosed within dashed lines). The structure 
of plasmenylcholine plasmalogen is shown. The ether bond occurs just proximal 
or vinyl to a carbon-carbon double bond. Collectively this group is a vinyl-ether 
linkage. Double bonds confer structural rigidity to the fatty acid side chain and 
affect phospholipid packing. The vinyl-ether linkage may explain why plasmalogens 
are more susceptible to phospholipase A2 mediated catabolism during ischemia. 
Abbreviations: i and j refer to the number of -CH2- groups contained within the fatty 
acid. 
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and coworkers deduced that the mysteriously stained substance was an aldehyde and not 
freely diffusible. The aldehyde became known as "plasmal" since it was discovered in the 
cell plasma, and the parent substance giving rise to the aldehyde was termed plasmalogen 
(Debuch and Seng, 1972). Since their discovery, plasmalogens have been isolated from cells 
in lower organisms and throughout the animal kingdom (Horrocks and Sharma, 1982). 
Mammalian Tissue Plasmalogen Distribution. 
Table 2 shows the plasmalogen content in selected human tissues. Plasmalogens are 
abundant in electrically active tissues and tissues that subserve ion and solute absorption (i.e., 
kidney). In contrast, hepatic tissue, which is not specialized for ion transport, contains only 
a low concentration of plasmalogen. Despite their emichrnent in membranes of excitable 
tissues, the physiological role of plasmalogens remains elusive. 
Within cardiac tissue, there are species differences in choline plasmalogen content 
(Table 3). In general, higher mammalian echelons contain the highest choline plasmalogen 
content. In human, porcine, bovine and rabbit, cardiac muscle, plasmalogens comprise 
nearly 40% of total choline-containing glycerophospholipid. However, diminutive amounts 
of choline plasmalogens are found in the rodent. Although the rat is a commonly used 
model for studying ischemia, the sequella resulting from alterations in plasmalogen 
catabolism in man would not be well represented in this model. 
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Table 2. Plasmalogen content in adult human1 
Tissue % Plasmalogen2 
Heart 32 
Skeletal Muscle 25 
Nerve 23 
Alimentary tract 1 6  
Kidney 1 2  
Liver 0.8 
1 Modified from Horrocks and Sharma, 1 982. 
2 Plasmalogen percentage relative to total phospholipid mass. 
Table 3. Species variation of cardiac choline plasmalogen content1 
Species % Choline glycerophospholipid 
Human 
Cow 
Rabbit 
Pig 
Rat 
Dog 
1 Modified from Horrocks and Sharma, 1982. 
2 Shaikh and Downar, 1981 
36 
46, 39 
d' 39, !j! 41 
362 
1 .7,1 .33 
57 (sarcolemma)4 
3 Schulz, Strynadka, Panas, Olley, and Lopaschuk, 1993 
4 Gross, 1984 
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Because of the difficulty in obtaining highly purified membrane subfractions, the 
major phospholipid constituent within each compartment (i.e., sarcolemma, mitochondria, 
etc.) is usually not reported. With the exception of canine myocardium, the plasmalogen 
data in Table 3 are normalized to total membrane choline phospholipid content. The vast 
majority of cardiac membranes is localized to the mitochondria, a membrane fraction 
comprising 75% of total phospholipid (Hazen and Gross, 1992). On the other hand, the 
electrically active sarcolemmal membrane fraction comprises a mere 2-8% of total 
phospholipid (Hazen and Gross, 1992; Corr et aI., 1995). Nevertheless, the majority of 
sarcolemmal choline phospholipids in canine myocardium are plasmalogens (Gross, 1984). 
Phospholipid Catabolism 1: PLA2 -Classifications. 
Lysolipids are derived from membrane diacyl- and plasmalogen-phospholipids by 
the actions of PLA2• This family of enzymes mediates the hydrolysis of sn-2 linked fatty 
acid from the parent phospholipid. The liberated products are a free fatty acid and lysolipid. 
Several PLA2 isoforms have been identified in heart. These enzymes are categorized based 
on their size, localization, substrate selectivity, pH-, and Ca2+-dependence (Corr et aI., 1995; 
Dennis, 1997). 
Activation o/Ca2+ -Independent Plasmalogen-Selective PLA2 During Myocardial Ischemia. 
Since there is a rapid increase in cellular lysolipid content during myocardial 
ischemia, traditional methodology has been used to elucidate the myocardial PLA2 isoform 
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that is activated by ischemia. However, enzymatic assays that utilized diacyl phospholipid 
substrates failed to detect increases in PLA2 activity (Grynberg, Nalbone, Degois, Leonardi, 
Athias and Lafont, 1988; Schwertz and Halverson, 1992). It was not until Ford and 
coworkers used choline plasmalogen as substrate that an increase in myocardial PLA2 
activity was detected (Ford, Hazen, Saffitz, and Gross, 199 1). Following 2 min of ischemia 
in isolated Langendorff perfused rabbit hearts, microsomal Ca2+ -independent PLA2 activity 
increased 4-fold with respect to control levels (Ford et aI., 199 1). Apparent maximal activity 
was achieved within 5-min of ischemia and exceeded basal levels by 10-fold. The time 
course of plasmalogen-selective PLA2 activity paralleled that of lactic acid accumulation, 
one of the earliest biochemical manifestations of myocardial ischemia. In contrast, when 
phosphatidylcholine, the diacyl phospholipid was used as the substrate, only a modest 
increase in PLA2 activity was observed following 15 min of ischemia. Enzymatic activity 
was completely reversible with 45 min of reperfusion. 
Subsequent characterization of the myocardial plasmalogen selective-PLA2 has 
revealed it to be a 40 kDa enzyme that is Ca2+ -independent, active at neutral pH, and requires 
association of both phosphofructokinase (PFK) and ATP or nonhydrolyzable ATP analogs 
for catalytic activity (Hazen and Gross, 199 1; Hazen and Gross, 1993; Hazen, Wolf, Ford 
and Gross, 1994; Gross, 1995). Recent evidence suggests that under nonischemic conditions, 
this enzyme is inhibited rather than activated by Ca2+ through a calmodulin-dependent 
process (Wolf and Gross, 1996). Ca2+-independent plasmalogen selective PLA2 comprises 
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greater than 95% of total PLA2 activity in explanted human heart (Hazen and Gross, 1992). 
In addition to heart, Ca2+-independent plasmalogen-selective PLA2s have been 
characterized in bovine brain, rabbit kidney, and rat and human pancreatic � cells. Bovine 
brain Ca2+ -independent plasmalogen-selective PLA2 is a 39 kDa cytosolic enzyme with a pH 
optimum of 7.4 (Farooqui, Yang and Horrocks, 1995). Although the specific activity for this 
enzyme is over 3 orders of magnitude less than that described for myocardial Ca2+­
independent PLA2, this disparity could have resulted from the use of different substrates 
(Farooqui et aI., 1995). The Ca2+ -independent plasmalogen-selective PLA2 in rabbit kidney 
is a 28 kDa cytosolic protein possessing a neutral pH optimum and is activated during brief 
hypoxia (Portilla, Shah, Lehman and Creer, 1994; Schonefeld, Noble, Bertorello, Mandel, 
Creer and Portilla, 1996; Portilla and Dai, 1996). Unlike the myocardial enzyme, catalytic 
activity for kidney PLA2 is not regulated by ATP or phosphofructokinase. Rat and human 
pancreatic �-cel1 PLA2 appear to have the same substrate selectively, pH optimum, and ATP 
dependence as that described for heart (Gross, Ramanadham, Kruszka, Han, and Turk, 1993; 
Gross, 1995). 
Cytosolic Ca2+ -independent PLA2s have been cloned in Chinese hamster ovary 
(CHO) cells (Tang, Kriz, Wolfman, Shaffer, Seehra and Jones, 1997) and murine 
macrophages (Ackermann, Kempner and Dennis, 1994). These enzymes are - 80 kDa, have 
95% amino acid sequence homology, and are believed to be identical enzymes from different 
species (Balboa, Balsinde, Jones and Dennis, 1997). Catalytic activity for the 80 kDa Ca2+_ 
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independent PLA2 is increased in the presence of ATP (Ackermann et al., 1994), which is 
similar to the regulation described for the myocardial enzyme (Hazen and Gross, 1991). 
However, whether the Ca2+-independent 80 kDa enzyme selectively hydrolyzes choline 
plasmalogens in preference to diacyl phospholipids (Figure 1) has not been reported. When 
compared with the 40 kDa myocardial PLA2 isoform, the distinguishing features of the 80 
kDa Ca2+-independent enzymes cloned from macrophage and P388D1 cell lines are their 
molecular weight and the presence of catalytic activity in the absence of binding to 
phosphofructokinase. At present, cloning of the myocardial 40 kDa Ca2+-independent 
plasmalogen-selective PLA2 has not been reported. Nevertheless, the cloning and 
characterization of Ca2+ -independent PLA2s from other cells lines have yielded a wealth of 
information regarding structure, function, and the regulation of these isoforms. 
Phospholipid Catabolism II: Lysophospholipid Catabolism. 
Lysophosphatidylcholine (LPC) or lysoplasmenylcholine (LPLC) are liberated from 
the PLA2-mediated attack of diacyl or plasmalogen phospholipids, respectively (Figure 2). 
Once produced, LPC can be rapidly catabolized by three distinct enzymes. 
Lysophospholipase catalyzes the sn-l hydrolysis of fatty acid from LPC and liberates 
glycerophosphorylcholine (GPC) and free-fatty acid (FFA). For every two moles of LPC 
produced, lysophospholipase transacylase catalyzes the formation of one mole each of 
phosphatidylcholine and glycerophosphorylcholine. Lastly, LPC-acyltransferase catalyzes 
the reacylation of fatty acid to LPC, producing a parent phospholipid. Because of these 
o " 
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Figure 2.Catabolism of choline diacyl and plasmalogen phospholipids in heart. Lysolipids are produced from the PLA2 
mediated hydrolysis of sn-2 fatty acid (FFA) from phosphatidylcholine (PC) or plasmenylcholine. The fate of LPC is 
determined by the activities of 3 different enzymes. LPC-acyltransferase catalyzes the sn-2 esterification of fatty acid 
to LPC producing phosphatidylcholine (PC). Lysophospholipase liberates the sn-1 fatty acid from LPC producing 
glycerophosphorylcholine (GPC) and FFA. For every 2 moles of LPC produced, LPC-transacylase catalyzes the 
production of 1 mole each of GPC and PC. Enzymes that catabolize LPC do not utilize LPLC as substrate. Only a 
low Iysoplasmalogenase activity has been reported in guinea pig heart. Thus, it is expected that activation of Ca2+­
independent PLA2 during myocardial ischemia results in the selective accumulation of sarcolemmal LPLC and may 
contribute to the electrophysiological sequella. 
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distinct enzyme systems, the rate of LPC catabolism exceeds production by over 100-fold 
under normal conditions (Corr et al., 1995). However, the rate of Iysoplasmalogen 
catabolism appears substantially slower than that of LPC (Gross, 1992). Lysoplasmalogen 
catabolism requires distinct enzyme isoforms whose activities are not well described (Gross, 
1992). For instance, Iysoplasmalogenase activity identified in guinea pig heart was found 
to depend on the type of detergent used for solubilization (Arthur, Page, Mock, and Choy, 
1986). Therefore, the relationship between enzymatic activity in the detergent extract and 
that in intact cells is unknown. Without detergent, no Iysoplasmalogenase activity was 
detected (Arthur et al., 1986). Other studies have failed to detect Iysoplasmalogenase 
activity (Gross, 1992). 
Ligand-Receptor Coupling to Ca2+-Independent Plasmalogen-Selective PLA2 During 
Myocardial Ischemia. 
Presently, there are no reports identifying a ligand or G protein-dependent receptor 
responsible for activating myocardial Ca2+-independent plasmalogen-selective PLA2 during 
ischemia. Gross ( 1995) has proposed a novel signaling pathway that couples the cellular 
energy state with glycolysis and phospholipolysis independently of the need for an 
extracellular ligand. Gross ( 1995) has suggested that sensing the cellular energy state is a 
property conferred on PLA2 by association with phosphofructokinase (PFK), a key glycolytic 
enzyme whose activity is tightly regulated by cellular ATP levels (Stryer, 1988a). By 
sensing a decreased cellular ATP concentration, PFK coordinately activates PLA2 resulting 
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i n  the release of free-fatty acid and Iysoplasmalogen (Gross, 1995). However, the 
confounding issue is the identity of the ATP pool detected by PFK. Decreases in bulk A TP 
levels are not observed until after 5 to 10 min of myocardial ischemia (Gettes and Cascio, 
1992), a time when maximum Ca2+ -independent plasmalogen-selective PLA2 activity is 
already manifest (Ford et at. , 199 1). Presumably, a reduction in the A TP concentration near 
the PLA2 enzyme is necessary (Gross, 1995). 
Alternatively, failure to identify a ligand responsible for the activation of Ca2+_ 
independent PLA2 activity in cardiac tissue does not preclude the possibility that one exists. 
In rat vascular smooth muscle, vasopressin stimulates the release of arachidonate from 
membrane phospholipids, which is largely mediated by Ca2+-independent plasmalogen­
selective PLA2 (Lehman, Brown, Rarnanadharn, Turk, and Gross, 1993). Furthermore, 
vasopressin receptors have been identified in rat heart (Xu and Gopalakrishnan, 1991). 
Whether vasopressin activates Ca2+ -independent plasmalogen- selective PLA2 in heart needs 
to be addressed. 
Vascular endothelial cells release LPC when stimulated with thrombin (McHowat 
and Corr, 1993). This process is a receptor mediated, protein kinase C (PKC)-dependent 
event, since pretreatment with the thrombin inhibitors hirudin and dansylarginine N-(3-ethyl-
1 ,5-pentanediyl) amide or blockade of PKC with H7 or staurosporine completely inhibit LPC 
accumulation following thrombin receptor stimulation. However, subclass-specific 
alterations in phospholipid catabolism were not reported. Thrombin receptor stimulation of 
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isolated rabbit ventricular myocytes has also been shown to result in significant increases of 
LPC content (Park, McHowat, Wolf, and Corr, 1994). These investigators argued against 
involvement of thrombin receptor activation of Ca2+-independent PLA2 because the 
thrombin-stimulated LPC accumulation depended on extracellular Ca2+ (Park et al., 1994). 
However, thrombin is a proteolytic enzyme that activates its receptor by cleaving the 
extracellular 42-arnino acid n-terminal extracellular domain of the receptor (Vu, Hung, 
Wheaton and Coughlin, 199 1). Thus, a tenable alternative explanation for the lack of LPC 
accumulation in Ca2+ -free media during exposure to thrombin is that the proteolytic activity 
of thrombin is a Ca2+ -dependent process. 
Rationale for Evaluating the Effects of LP LC on Cardiac Electrophysiology. 
A large body of iiterature supports the idea that accumulation of lysophospholipids 
during myocardial ischemia contributes to the electrophysiological sequella that shortly 
follow (for review, see Corr et al., 1995). These electrical disturbances may underlie the 
malignant ventricular arrhythmias responsible for the majority of sudden cardiac deaths. It 
is well documented that LPC, a lysolipid derived from diacyl phospholipids, is 
arrhythmogenic. However, the arrhythmogenic potential of lysolipids derived from 
plasmalogen phospholipids has not been evaluated. Plasmalogens are abundant III 
electrically excitable tissue and represent the major choline containing subclass of 
phospholipids in cardiac sarcolemma. Lysoplasmenylcholine is selectively liberated from 
choline plasmalogen by the 40 kDa myocardial Ca2+-independent PLA2 that is rapidly 
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activated during brief ischemia. This enzyme isoform is highly abundant in human 
myocardium comprising over 95% of total PLA2 activity. Once produced, the clearance of 
LPLC is substantially slower than that of LPC due to low enzymatic activity for 
Iysoplasmalogens. Taken together, selective hydrolysis and slow catabolism of 
Iysoplasmalogens suggest that subclass-specific alterations in plasmalogen phospholipid 
catabolism during myocardial ischemia is important. Consequently, this thesis was 
undertaken to evaluate the e1ectrophysiological effects of LPLC in cardiac ventricular 
myocytes using the patch clamp technique. 
Experiments revealed that at the lowest concentrations, LPLC induced spontaneous 
contractions in ventricular myocytes significantly faster than LPC. The spontaneous activity 
was attributed to an LPLC-induced sustained depolarization of - 50 m V from the resting 
membrane potential. The time to depolarization in LPLC was both temperature- and dose­
dependent. The ionic basis of the LPLC-induced depolarization was through activation of 
a cationic non-selective current that reversed at - -19  m V and appeared voltage- and time -
independent. The LPLC-induced conductance depended on bath Na+ concentration and had 
an estimated PN/PK ratio of 0 . 1 .  However, the conductance was insensitive to 
pharmacological blockade ofNa- ,Ca-, and stretch activated-channels. The LPLC-induced 
conductance was inhibited by the trivalent lanthanides, La3+ and Gd3+. Consistent with 
electrophysiological studies, lanthanides delayed the LPLC-induced spontaneous 
contractions, but pharmacological blockade of Ca-channe1s was ineffective. Consistent with 
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the amphiphile's effects on membrane currents, LPLC prolonged terminal repolarization of 
the ventricular action potential and caused depolarization of the resting membrane potential 
that ultimately culminated in the loss of excitability. These effects are predisposing factors 
for malignant ventricular arrhythmias. Consequently, subclass-specific alterations in 
phospholipid catabolism resulting in the sarcolemmal accumulation of LPLC are likely to 
be important contributors to the electrophysiological sequella during myocardial ischemia. 
Chapter 2 - Methods 
Myocyte Isolation. 
Ventricular myocytes were isolated from New Zealand white rabbits (2.0 - 3.0 kg) 
of either sex using a Langendorff apparatus and a collagenase-protease digestion procedure 
(Dudley and Baumgarten, 1993). Rabbits were sedated by intramuscular administration of 
acepromazine maleate (5 mg/kg) and xylazine (10 mg/kg), followed by induction of 
anesthesia with ketamine HCl (50 mg/kg). Following deep anesthesia, hearts were rapidly 
excised and rinsed in a heparinized ( 10  U/mL) Tyrodes solution containing (in mM): 1 3 0  
NaCl, 5 . 4  KCl, 3 . 5  MgCI2, 0.4 NaH2P04, 10 glucose, 2 0  taurine, 1 0  creatine, 0. 1 ethylene 
glycol-bis(�-aminoethyl ether N,N,N' ,N' -tetraacetic acid (EGTA), 5 4-(2-hydroxyethyl)-I ­
piperazineethanesulfonic acid (HEPES), titrated to p H  7.3 with I N  NaOH. Next, the aorta 
was cannulated using a 15 gauge Luer stub adaptor, attached to a column, and retrogradedly 
perfused with Tyrodes solution gassed with 1 00% O2 and maintained at 37 °C. The cell 
isolation protocol consisted of an initial 4-6 min perfusion with Tyrodes solution containing 
0.75 mM CaCl2 without EGTA, followed by a 3-5 minute perfusion in Ca2+-free Tyrodes 
containing 0. 1 mM EGTA as previously described (Dudley and Baumgarten, 1993). In latter 
experiments, faster cell isolations with improved morphology were obtained by omitting the 
initial perfusion with Ca2+-Tyrodes solution. Subsequently, the perfusate was switched to 
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enzyme solution containing I mg/mL collagenase (type II; Worthington Biochemical 
Corporation, Freehold, NJ) and 0. 1 mg/mL protease (type XIV; Sigma Chemical Co. St. 
Louis, MO) in 80 !-1M Ca2+-Tyrodes. This solution was collected and recirculated for 1 1 -13  
min. Next, septal and ventricular free wall tissue was dissected, cut into course strips (� 5 
x 5 mm), and placed in separate Erlenmeyer flasks containing enzyme solution supplemented 
with 1 0% bovine serum albumin (#A-7906, Sigma). Flasks were agitated in a shaker bath 
at 37 DC for 2-3 min. Individual myocytes were collected by filtration of the septal and 
ventricular free wall tissue through nylon mesh (� 250 um pore size) into separate centrifuge 
tubes containing 80 !-1M Ca2+ -Tyrodes solution. After a 4 min centrifugation at 1 1  x g, the 
supernatant was removed, and the pellet was resuspended in room temperature Kraft-Bruhe 
solution containing (in mM): 80 K-glutarnate, 10 KH2P04, 0.5 EGTA, 2.5 KCI, 1 .8 MgS04, 
10 HEPES, 1 1  glucose, 10 taurine, titrated to pH 7.3 with KOH. Myocytes were washed 
once and stored in Kraft-Bruhe solution until used. A typical isolation yielded 60-70% 
viable cells, and all experiments were performed within 10 h of isolation. Myocytes selected 
for study had clear striations, were free of membrane blebs, and were quiescent. 
Bath and Pipette Solutions. 
The standard bath solution for spontaneous activity and electrophysiological studies 
contained (in mM): 140 NaCl, 5 KCI, 1 MgCI2, 1.8 CaCI2, 5 HEPES, titrated to pH 7.4 with 
NaOH. The pipette (internal) solution for whole-cell electrophysiological recordings 
contained (in mM): 140 K-aspartate, 5 K2EGTA, 5 MgCI2, 5 N3zATP, 0.4 Na3GTP, 0.062 
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CaCI2, 5 HEPES titrated to pH 7.1 with KOH. For experiments in low extracellular Na+ , 126 
mM NaCI was replaced with equimolar N-methyl-d-glucamine (NMDG) chloride. For 
experiments in low extracellular Cl·, 135.5 mM NaCI was replaced with equimolar Na­
isethionate. For experiments performed in hypertonic conditions, the bath solution was 
supplemented with mannitol (fmal concentration = 1 50 mM; relative osmolarity = 1 .5). 
Tetrodotoxin (TTX), saxitoxin (STX) (Calbiochem, La Jolla, CA), lanthanides (Gd3+, La3+), 
and Cd2+ were dissolved directly in the bath solution. 
Two lysolipids were studied: l -alk-O-l -enyl-lysoplasmenylcholine (LPLC) was a 
natural product derived bovine heart (Doosan Serdary Research, Englewood Cliffs, NJ) and 
synthetic l -alk-l -palmitoyl-lysophosphatidylcholine (LPC; purity -99%, Sigma). Aliquots 
ofLPLC (range 10.3-104 ilL) in CHC� were evaporated to dryness under a N2 atmosphere 
to limit oxidation, resuspended in the bath solution, and sonicated for 2 min. The effects of 
CHCl3 were not investigated since only a negligible fraction of solvent likely remained 
following evaporation (following evaporation, residual ACS grade CHCl3 is < 0.00 1 %; # 
C298, Fisher Scientific, Pittsburgh, PA). Aliquots ofLPC (Sigma) from a i D mM stock in 
deionized H20 were dissolved in the bath solution to make the indicated concentrations and 
sonicated for 2 minutes. All experiments were performed at room temperature (-23 °C). 
Nominal Formula Weight Determination /or Lysoplasmenylcholine. 
Because synthetic lysoplasmenylcholine is not commercially available, the natural 
product derived from bovine cardiac membrane phospholipids was utilized in this study. 
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Sample analysis provided by the vendor indicated that > 80% of the starting choline 
phospholipid was plasmalogen « 20% diacyl phospholipid). The final lysolipid product was 
� 99% of the total phospholipid (personal communication, Mark Olbrychski, Doosan 
Serdary Research). Based on the starting choline plasmalogen content and the sn-I fatty acid 
analysis provided (Table 4), a nominal formula weight (NFW) was determined using the 
following formula: 
NFW (g/mol) = 279.44 + I,X,FW, 
where X, and FW , is the mole fraction and formula weight of the sn-l fatty acids 
respectively. The constant, 279.44, was obtained from the relative combined formula 
weights of the subclass specific glycerophosphorylcholine backbone as follows: 
279.44 glmol = 0.8 x FWplasmgngpc + 0.2 x FWd;acylgpc 
where FWplasmgngpc is the base formula weight of plasmalogen glycerophosphorylcholine 
(CIOH2106NP), including the sn-I vinyl ether group and FWd;acylgpc is the base formula weight 
of diacyl glycerophosphorylcholine (C8HI907NP) including the sn-I oxygen ester. The 
nominal formula weight was calculated to be 517.16 glmo!. Thus, a 1 !-lmole sample should 
contain between 0.8 and 1 !-lmole of lysoplasmenylcholine and between 0 and 0.2 !-lmol of 
Iysophosphatidylcholine. 
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Table 4. Fatty acid (sn- 1 )  analysis of Iysolipid sample containing predominantly 
Iysoplasmenylcholine from bovine heart. 1 
Species2 Formula X3 FW' X x FW 
14 :0 C14H27 trace 195.36 
1 6 :0 C16H31 0.462 223.41 1 03.21 
1 8:0 C18H35 0 . 193 251 .46 48.53 
18 : 1  C18H33 0.1 1 3  249.44 28. 19  
1 8:2 C18H31 0 . 189 247.43 46.76 
18:3 C18H29 0.014 245.41 3.43 
20:0 C2oH39 trace 279.51 
20:4 C2oH31 0.028 271 .45 7.60 
'[X,fW;= 238 g/mole 
1000san Serdary Research, Englewood Cliffs, NJ, (catalog# A-354) 
2Number of carbon atoms : number of carbon double bonds 
3M ole fraction 
4Formula weight in g/mol 
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Spontaneous Activity and Whole-Cell Measurements. 
Myocytes were placed in a flowing bath chamber mounted on the stage of an 
inverted microscope (Nikon, Tokyo, Japan) and superfused at 1 -2 mL/min. The 
microscope was supported on an air table (Technical Manufacturing Corp. Peabody, MA). 
Myocytes were observed using Hoffmann modulation contrast optics and a TV monitor 
(Javelin Electronics Inc . ,  Torrance, CA) connected to the microscope by video camera 
(charge coupled device; Sony, Japan). For spontaneous activity experiments, a field of 
myocytes were viewed under low power (1 Ox objective). The time of spontaneous activity 
was recorded for each cell after switching to the indicated lysolipid-containing solution. 
Following a 10 min equilibration, myocytes were observed for up to 60 min in control 
solution and during exposure to each Iysolipid. 
For whole-cell recordings, pipettes were fabricated from 7740 (0.84 mm i.d., 1.5 mm 
o.d.) or 7052 (1.0 mm i.d., 1.5 mm o.d.) glass, coated with Sylgard 184 (Dow Coming, 
Midland MI) and fire-polished. The pipette resistance ranged from 1- 3 MQ. A Ag/AgCl2 
pellet connected to the bath via a 0 .15 or 3 M KCl containing agar bridge served as the 
ground electrode. A List model EP-7 amplifier (List-Medical, Darmstadt-Eberstat, FRO) 
was used to patch clamp myocytes in the whole-cell configuration. The diffusion potential 
between pipette and bath solutions, measured as Eb,'h - Ep,pette (Neher, 1992), was 13. 1  ± 0.2 
mV (n=4), and all voltages have been corrected by this amount. Voltage- and current- clamp 
protocols for data acquisition where controlled by computer programs written in ASYST 
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(Keithly-Asyst, Taunton, MA). 
For ionic current measurement, membrane potential was controlled using the voltage 
clamp mode of the patch clamp amplifier (Hammill, Neher, Sakmann, and Sigworth, 198 1). 
Ionic currents were elicited by 200 ms voltage pulses from - 1 1 3  to 37 mV in l O-mV 
increments from a holding potential of -83 mY. The cycle length was 2 s (0.5 Hz). The 
current output was filtered at 2 kHz (-3 dB, 8 pole Bessel; Frequency Devices, Haverhill, 
MA) and digitized at 10 kHz (12 bits). The quasi steady-state current, averaged over the last 
1 6.7 ms of each voltage step is plotted in the current-voltage (I-V) relations. 
Series resistance was determined from the integral and time constant of the capacity 
current decay. The time constant was evaluated by fitting the time course of the exponential 
current decay obtained from the average of 16 l O-mV hyperpolarizing voltage pulses, 200 
ms in duration. Membrane capacitance was determined by evaluating f I..pdt, where Ionp is 
the capacity current evaluated from t = 0 to t = S"tau (93.3% of the capacity current). The 
integrated result is the charge moved across the membrane capacitor. This value was divided 
by the voltage step to give membrane capacitance. When R,'ri" « membrane resistance (R",), 
R,'rios can be calculated from the time constant and membrane capacitance by: 
where R,"ios is in ohms, "tau is the time constant in seconds, and em is the membrane 
capacitance in farads. R"'i" averaged 7.7 ± 2.5 MQ (n=26). In all experiments, R "rios 
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compensation circuitry was utilized to minimize the error of  the command voltages. 
Compensation is based on prediction of R..rios using analog circuitry. This prediction is used 
to a scale a fraction of the whole-cell current output which is fed back to the command 
potential and effectively minimizes the voltage drop across R,e,;es' Rse,;es was compensated 
by ;, 40% in all experiments. Still, the maximum voltage error arising from the 
uncompensated resistance became substantial at potentials sufficiently negative to the 
holding potential (i.e., � 6 m V for 2 nA). However, better voltage control was obtained at 
potentials positive to -83 m V where steady-state membrane currents usually were less than 
2 nA. 
Membrane potential data were acquired under current -clamp mode of the patch clamp 
amplifier. Resting membrane potential (Em ) data were filtered at 500 Hz, digitized at I kHz 
and recorded in real-time with a strip chart recorder (Gould, Cleveland, OH). Action 
potentials were evoked by current stimuli (0.7-1 .5 nA) 3-5 ms in duration at a cycle length 
of2 s (0.5 Hz). Action potential data were filtered at I kHz and digitized at 3 kHz. 
Data Analysis and Statistics. 
Current- and voltage-clamp data were analyzed with customized programs in ASYST 
and plotted using Sigma Plot 2.0 for Windows 3 . 1 1  (Jandel Scientific, San Rafael, CA). 
Results are reported as mean ± s.e.m where indicated. For spontaneous activity experiments, 
multiple comparisons were made on median response times for each lysolipid and 
experimental protocol using Dunn's method following a one-way analysis of variance 
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(ANOVA) on ranks. Comparisons for patch clamp data were made using Student-Newman­
Keuls method following ANOV A or t-test where indicated. Statistics were computed using 
Sigma Stat 2.0 (Jandel Scientific). For all comparisons, P < 0.05 was considered significant. 
Chapter 3 - Results 
Evaluation of the Arrhythmogenic Potential of LP LC 
When bathed in physiological saline solution, dissociated ventricular myocytes are 
nonnally quiescent and have stable resting potentials. Upon exposure to ischemic 
metabolites of diacyl phospholipid catabolism (i.e., lysophosphatidylcholine), myocytes 
exhibit spontaneous contractions (Liu et aI., 1991) and die (Donck and Borgers, 1 991). Until 
recently (Alvennann et al., 1992; Caldwell and Baumgarten, 1996), there were no reports 
characterizing the effects of plasmalogen metabolites on ventricular myocytes. This is 
surprising since plasmalogens are selectively enriched in cardiac membranes (Gross, 1984), 
more vulnerable to attack by PLA2 during myocardial ischemia (Ford et al., 1 99 1), and 
plasmalogen metabolites are cleared from myocardial membranes more slowly than their 
diacyl analogs (Gross, 1 992). Lysoplasmenylcholine (LPLC) is a product of choline 
plasmalogen catabolism. To determine ifLPLC possessed similar arrhythmogenic properties 
to that described for LPC, the effects of LPLC on freshly dissociated and unclamped 
ventricular myocytes were compared with those observed with lysophosphatidylcholine 
(LPC) under identical conditions. Figure 3 is a survival plot of the fraction of myocytes 
remaining quiescent with time following exposure to different concentrations of LPLC or 
LPC. Induction of spontaneous contractions was found to depend on the dose and subclass 
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Figure 3. Lysolipids induce spontaneous activity in myocytes. Myocytes were exposed to LPLC (solid symbols) or 
LPC (open symbols) and observed for up to 60 min. The fraction of cells remaining quiescent is plotted at selected 
times. At 2.S and S 11M, LPLC induced spontaneous activity significantly faster than LPC. The median times were: 
LPLC, 27.4 (n = 36) and 16.4 min (n = 64); LPC, >60 (n = 29) and 37.8 min (n = 48). Median times for 1 0  11M Iysolipids 
were not different (LPLC, 8.2 min (n = 62); LPC, 8.7 min (n = 1 S». All control myocytes remained quiescent for 60 min 
(n = 20, data not shown). (P < O.OS, Dunn's method following ANOVA on ranks; temperature = 23. 1 ± 0.1  °C). 
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of lysolipid. At the lowest concentrations, 2.5 and 5 �M, LPLC induced spontaneous 
contractions in myocytes significantly faster than the corresponding doses of LPC. 
Spontaneous activity developed with median times of 27.4 (n = 36), and 1 6.4 min (n = 64) 
for 2.5 and 5 �M LPLC, respectively, compared with > 60 (n = 29), and 37.8 min (n = 48) 
for LPC. There were no differences in the median times to development of spontaneous 
activity at 10 �M doses (LPLC, 8.2 min (n = 62); LPC 8.7 min (n = 1 5» , however. The 
experimental endpoint for the study was 60 min, and under control conditions all myocytes 
remained quiescent for this time (n = 20; data not shown). Thus, when median times were 
compared for the development of spontaneous contractions between different lysolipid 
subclasses, LPLC, the lysolipid selectively liberated by PLA2 during myocardial ischemia, 
induced spontaneous contractions significantly faster than LPC under identical conditions. 
Electrophysiological Mechanism Responsible for LP LC-Induced Contractions. 
To investigate the electrophysiological mechanism underlying the spontaneous 
activity observed in LPLC, the resting transmembrane potential of dialyzed myocytes was 
recorded. These measurements were made using the patch clamp amplifier set to current­
clamp mode (I = 0). Figure 4 shows the resting potential from a representative ventricular 
myocyte. Under control conditions, the resting potential was stable and well-polarized at -83 
mV (mean = -83.5 ± 0.2 mY; n = 17). However, within 7 min of exposing the cell to 10 �M 
LPLC, the membrane potential underwent an abrupt and sustained depolarization to -24 mY. 
Partial recovery of the resting potential could be achieved early following depolarization in 
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Figure 4. Lysoplasmenylcholine induced membrane depolarization .  Within 7 min of exposure to 1 0  IJM LPLC, Em 
abruptly depolarized from -83 to -24 mV. Hyperpolarizing current pulses (75 pA) were applied at a-c, and bistability 
was observed (b). Following depolarization, input resistance increased 5-fold (compare c with a). This excludes 
gigaseal deterioration as the cause of depolarization. Small transient depolarizations (-5 mV, arrow) frequently were 
observed preceding the abrupt depolarization. These small transient depolarizations also were observed in the 
presence of nx, and low [Na+)o (not shown). VC indicates voltage clamp (command pulses suppressed). Break in 
record was a 2-min control period. 
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LPLC by injecting 75-pA hyperpolarizing current pulses, 200 ms in duration (Figure 4(b)). 
Thus, the cell exhibited bistable resting potentials. Bistability occurs when there are two 
stable zero-current potentials (Hutter and Noble, 1961);  that is to say, the current-voltage (I­
V) relationship crosses the zero-current axis with a positive slope at two voltages. These 
voltages correspond to the well-polarized resting value and a more depolarized potential, 
separated by a region having a negative-slope conductance (Baumgarten and Fozzard, 1 992). 
Transition from the depolarized to the well-polarized resting potential can be achieved by 
a current stimulus, sufficient in magnitude, to surmount the voltage range having a negative­
slope conductance. In Figure 4(b), the control resting membrane potential could be restored 
almost completely by hyperpolarizing current (75-pA) pulses following membrane 
depolarization in LPLC. Bistability of the resting potential was an early manifestation of 
LPLC. Longer exposure resulted in complete loss of the ability to recover the resting 
membrane potential, even with 150-pA hyperpolarizing current pulses. 
The time to depolarization in LPLC was dose-dependent and is shown in Table 5. 
These values are comparable to the median times for development of spontaneous 
contractions observed with equimolar LPLC (Figure 3). The lag phase may reflect the time 
necessary for requisite sarcolemmal LPLC accumulation. 
Following depolarization in LPLC, the well-polarized resting membrane potential 
observed under control conditions could not be fully recovered upon washout of the lysolipid 
from the bath. Even supplementing the bath solution with 5 mglmL albumin, which hastens 
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Table 5. Dose-dependence of time to depolarization. 
LPLC (!-1M) ttd (min)l sem n 
1 0  3.0 0.5 6 
5 9.0 1 .5 1 1  
2.5 31 . 1  7.4 3 
lttd; mean time to depolarization 
40 
Iysolipid extraction from the membrane (Man, Kinnaird, BihIer and Choy, 1990; Mohandas, 
Wyatt, Mel, Rossi, and Shohet, 1982), failed to restore the control resting potential in 4 out 
of 5 cells. Under control conditions, cells selected for study had stable, well-polarized 
resting potentials (" -80 mY) for up to 60 min (n = 5, data not shown). On occasion, some 
myocytes exhibited fluctuating resting potentials and underwent depolarizations to - 0 m V 
concomitant with apparent reduction in input resistance (Rinp.)' This was believed to result 
from a loss of seal resistance CR.e,') and these cells were not included in the analysis. 
Myocytes spontaneously depolarized significantly faster in LPLC at colder 
temperatures when compared with room temperature (23. 1  ± 0.1 0c). The mean time to 
depolarization in 2.5 �M LPLC at 10 °C was 9 . 1  ± 2.0 min, (n = 4) compared with 3 1 . 1  ± 
7 . 1  min at 23 °C (n = 3). Although the mechanism responsible for the temperature 
dependence of the time to depolarization is unknown, a similar effect of temperature has 
been described for the hemolytic activity ofLPC in erythrocytes (Weltzien, 1979). However, 
because temperature can alter enzyme kinetics, membrane molecular dynamics, and lipid 
solubility, these alterations alone or in combination could have contributed to the shorter 
depolarization times observed at cooler temperatures. Therefore, additional experiments 
characterizing the effect of temperature on the LPLC-induced electrophysiological alterations 
were not performed. 
The LPLC-induced depolarization of patch clamped myocytes could be due to an 
effect of LPLC on the sarcolemma or disruption of the gigaseal between the cell membrane 
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and the patch pipette. These two possibilities can b e  distinguished b y  considering the 
response to constant current pulses, such as in Figure 4, and the equivalent circuit. The 
magnitude of the change in voltage ( I LlE i )  with constant current stimuli increased 5-fold 
during the LPLC-induced membrane depolarization (c) as compared to that under control 
conditions (a). This can be analyzed with Ohm's Law: 
LlE = I R;np, 
where LlE is defined above, I is the current, and R;np, is the input resistance. R;np, is the sum 
of the series combination of membrane (R,.) and pipette access (R.ceess) resistance in parallel 
to the seal resistance (R.eal), or: 
Thus, for an increased LlE, R;np, must have increased by the same factor (I = constant). An 
evaluation of each resistive element follows. In the whole-cell configuration, Rseal is in 
parallel to the other resistive elements and cannot be uniquely determined. R.eal can be 
measured, however, in the cell-attached patch configuration. Typically, Rseal is on the order 
of several to tens of gigaohms. A reduction in R.eal would lead to an apparent depolarization 
of membrane potential as observed, but would decrease R;np,. An increased R.eeess would 
result in a larger LlE with constant I stimulus. In addition, an increased R.ceess would lead to 
an artifactual membrane depolarization, but only ifR.ceess approached the input resistance of 
the amplifier. This can be readily seen from the voltage divider equation: 
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where V ob, is the observed resting transmembrane voltage, Vact is the actual transmembrane 
voltage, Rin is the input resistance of the patch-clamp amplifier, and Raeees, is defined above. 
However, Raeee,,, measured under voltage-clamp conditions (see methods), averaged 7.7 ± 
2.5 MQ (n = 26) and is negligible compared to Rin (i.e., when Raccess """ Rin, Vobs '" Vae,). Thus, 
changes in Raeeess are unlikely to be responsible for the observed membrane depolarization 
concomitant with an increase R;np,. The remaining resistive element is Rm. Rm is a complex 
function of membrane potential (Weidmann, 1951) .  At the normal resting potential, R,. is 
low as a result of the high resting inwardly rectifying K-channel conductance (gKI).  
However, during the plateau phase of the ventricular action potential, R,. is dramatically 
increased. This is because gKI decreases on depolarization. It is not until near complete 
repolarization is achieved by the delayed rectifier K-current that gKI increases and the low 
resting value of Rm is restored. Thus, the increased t.E observed following depolarization 
in LPLC most likely is due to an increased Rinp, and is consistent with the voltage­
dependence ofR,. (Weidmann, 1 951 ). However, alternative explanations involving changes 
in multiple resistive elements cannot be ruled out. 
Characterization of the Ionic Current Underlying the LPLC-induced Membrane 
Depolarization. 
To investigate the mechanism responsible for the membrane depolarization in LPLC, 
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myocytes were voltage clamped to measure steady-state ionic currents. Figure 5 shows the 
voltage protocol and resulting ionic currents from a representative myocyte under control 
conditions, and following a 9-min exposure to 5 11M LPLC. Currents were elicited by 
stepping the transmembrane voltage from the holding potential (\/holcU, -83 mY, to potentials 
between - 1 1 3  and 37 m V in 10-m V increments; the step duration was 200 ms. Under control 
conditions, the current at Vho1d was near zero (indicated by - ), and the steady-state 
currents at the end of each voltage step exhibited inward rectification. The saturating fast 
component near the beginning of each trace was due to the voltage-dependent Na-current. 
Compared with control, the magnitude of the steady-state membrane current in LPLC 
increased at all voltages except for near -20 m V where it reversed direction. A net inward 
(depolarizing) current can be clearly seen in Figure 5 at Vho1d following exposure to LPLC. 
This current is responsible for the LPLC-induced membrane depolarization described 
previously. 
The effect ofLPLC on the membrane current-voltage (I-V) relationship is plotted in 
Figure 6. Symbols represent the current averaged over the last 16.7 ms of each voltage-step 
to eliminate any contribution from 60 Hz noise. Panel A shows the raw currents under 
control conditions (e) and following exposure to 5 11M LPLC (II). In control myocytes, the 
current-voltage relationship exhibited an UN-shaped" appearance, predominantly due to the 
inwardly-rectifying K-current (lKI) (Giles and Imaizurni, 1 988). Following a 9-min exposure 
to LPLC, an inward (depolarizing) current developed at the holding potential (-83 mY). 
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Figure 5. Effect of Iysoplasmenylcholine on membrane currents. To investigate the 
ionic basis of the LPLC-induced membrane depolarization, quasi steady-state 
membrane currents were measured under voltage-clamp. Currents were elicited 
by 200-ms depolarizations from a holding potential of -83 mV to potentials between 
-1 1 3  and 37 mV in 1 0-mV increments in control and during exposure to 5 IJM LPLC. 
A) Prior to the voltage step, the current at -83 mV was close to zero (indicated by 
- ) reflecting the myocyte's well-polarized resting potential. Steady-state 
membrane currents displayed inward rectification indicated by smaller currents at 
positive potentials. 8) However, within 9-mins of exposure, LPLC induced a net 
inward (depolarizing) current at -83 mV and increased steady-state membrane 
currents. 
ex, 
v.> 
3 
< 
(JI 
co 
3 
5' 
(JI 
c 
s: 
A. 
2 
o I -=- =� •••• 
« -2 c mV 
_E 
-4 
--.- Control 
-- LPLC (5 Il M) 
-6 
-8 
8.  
2 
� 0 I��-�::--I-���=-
-1 
• ...-=i 
:g -1 
-2 � LPLC - Control 
-3 
-4 
46 
Figure 6. Membrane current underlying LPLC-induced depolarization. (A) Steady-state I-V relationships in control 
solution and after 9 min in 5 �M LPLC. Currents at the end of 200-ms command pulses are plotted. (8) LPLC-induced 
current (i.e. difference current) was obtained by subtracting the control current from that in LPLC. Erev was -18.5 ± 0.9 
mV (n = 9). Often, as in this example, the LPLC-induced current exhibited inward-going rectification. In other cases, 
it was more linear. 
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Shown in panel B is the LPLC-induced current. The LPLC-induced current was obtained 
by digitally subtracting the raw steady-state current-voltage relationship in control from that 
in LPLC (panel A). The LPLC-induced current exhibited variable amounts of rectification 
at negative potentials and had a reversal potential (E,.v) of -18.5 ± 0.9 mV (n = 9). Since the 
E"v did not correspond to the equilibrium potential for any of the permeant ions contained 
in the bath or pipette solutions, the LPLC-induced current likely resulted from a poorly 
selective ionic conductance, or from multiple time-independent conductances. Following 
induction, the current in the presence ofLPLC rapidly increased with time and precluded a 
stable estimate of membrane conductance. Attempts to washout LPLC failed to restore the 
I-V relationship to its control configuration. 
Ionic Basis of the LPLC-Induced Current. 
Next, the ionic basis for the LPLC-induced current was explored. One possibility is 
that Na-channel gating could contribute to the sustained inward current and membrane 
depolarization caused by LPLC. Exposing myocytes to relatively high LPC concentrations 
(9-25 �M) for extended periods (up to 2 h) modifies the voltage-dependence and gating 
kinetics of single cardiac Na-channels (Burnashev et al. , 1 989; Burnashev et al., 1991; 
Undrovinas et a!. , 1992). These alterations can be inhibited with QX-222, a permanently 
charged lidocaine derivative and Na-channel blocker (Undrovinas et a!. , 1992; Undrovinas 
and Makielski, 1996). Shorter exposures (between 1 to 10 min) to similar concentrations of 
LPC reduces macroscopic peak currents, and slows Na-channel inactivation kinetics (Sato 
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et al., 1 992; Shander et aI., 1996). The LPC-induced slowing of macroscopic current decay 
could lead to a persistent Na-current and depolarization of the resting membrane potential 
despite the fact that it reduces peak current. LPLC-modified cardiac Na-channels may 
behave in a similar fashion. If this were the case, then the LPLC-induced membrane 
depolarization and ionic currents should be sensitive to reductions in bath Na+ and inhibited 
by the Na-channel blocking guanidinium toxins, tetrodotoxin (TTX) and saxitoxin (STX). 
Figure 7 shows the effects of a 1 0-fold reduction in bath Na+ and I �M STX on the 
membrane potential profile and ionic currents from a representative myocyte in control and 
following exposure to 5 �M LPLC. In Figure 7 A, the control resting membrane potential 
was - -80 mY. Reducing bath Na+ from 140 to 14 mM (equimolar replacement with N­
methyl-d-glucamine) caused a modest but significant reversible membrane depolarization 
of2.6 ± 0.5 mV (P = 0.016, n = I S). After returning to physiological bath Na+, LPLC caused 
an abrupt membrane depolarization to -23 mY. A I O-fold reduction in bath Na+ resulted in 
a reversible and nearly complete recovery of the control resting potential during exposure to 
LPLC (range -65 to -80 m V). However, pharmacological blockade of cardiac Na-channels 
with I �M STX failed to inhibit the membrane depolarization in LPLC upon returning to 140 
mM bath Na+. Although LPC-modified Na-channels remained susceptible to block by QX-
222 (Undrovinas et aI., 1992; Undrovinas and Makielski, 1 996), it was possible that LPLC­
modified Na-channels no longer could be blocked by guanidinium toxins. This possibility 
was ruled out by pretreating myocytes with I 0 �M TTX prior to LPLC exposure; this 
maneuver failed to prevent or delay membrane depolarization in LPLC (n = 4, data not 
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Figure 7. LPLC-induced depolarization is INa+lo-dependent but insensitive to guanidinium toxins. (A) Following 
depolarization in 5 iJM LPLC (140 mM IN a+]o) , reducing INa+]o to 14  mM reversibly restored Em (n=3). In contrast, 1 
iJM STX (n=3) and 1 0  iJM TTX (n=3, not shown) failed to restore Em or prevent LPLC-induced depolarization. (8) 
LPLC-induced currents from the same cell as in (A). The LPLC-induced current was INa+lo-dependent but insensitive 
to STX. Low INa+]o caused a -26.7 ± 4.2 mV (n = 6) shift in Erev and inhibited the LPLC-induced current by 56.6 ± 3.6% 
at -83 mV (n=4). Similar results were obtained with 1 0  iJM TTX (n=4, data not shown). The shift in Erev of the LPLC­
induced current is equivalent to that expected for a channel with a PN.tPK ratio of 0. 1 2  ± 0.06 (n = 6). 
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shown). 
Consistent with the lack of effect on membrane potential, STX also failed to inhibit 
the LPLC-induced current (Figure 7B). In contrast, a l a-fold reduction in bath Na+ shifted 
the reversal potential of the LPLC-induced current by -26.7 ± 4.2 mV (n = 6) and inhibited 
the current by 56.6 ± 3.6% at -83 mV (n = 3). Based on the shift in reversal potential, and 
assuming that only K+ and Na+ contribute to the LPLC-induced conductance, the PNalPK ratio 
was 0.12 ± 0 .06 (n = 6). Thus, the LPLC-induced membrane depolarization and ionic 
current were sensitive to changes in bath Na+, but independent of Na-channel blockade by 
guanidinium toxins. 
To determine if voltage-dependent Ca-channels contributed to the LPLC-induced 
current, Ca-channels were inhibited by Cd2+. Figure 8A shows the steady-state I-V 
relationship from a representative myocyte in control solution (e), after 6 min in 1 0  �M 
LPLC (.), and following Ca-channel blockade with 100 �M Cd2+ (.t.). Neither the increased 
conductance nor the reversal potential of the current observed in LPLC were affected by Ca­
channel blockade with Cd2+ (Figure 8B, n = 3). Others have reported inhibition of the 
cardiac Ca-current by 5 �M LPLC (Alvermann et al. , 1992). Thus, assuming voltage 
sensitive Ca-channels remain sensitive to block by Cd2+ following exposure to LPLC, it is 
unlikely that theses channels directly contribute to the LPLC-induced current. Consequently, 
alternative mechanisms responsible for Ca2+ -overload during exposure to LPLC should be 
considered (see Discussion). 
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Figure 8. The LPLC-induced current was not affected by Ca2+ channel blockade (n = 3). (A) Membrane currents in 
control solution, after 6 min in 10 IJM LPLC, and after addition of 1 00 IJM Cd2+. (8) LPLC-induced current in the 
presence and absence of Cd2+. 
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Because the LPLC-induced current exhibited a poorly selective conductance, and 
under the experimental conditions (see Methods) the calculated Nernst potential for Cl- was 
" -70 mY, the Ct contribution to the LPLC-induced current was evaluated. If Cl­
contributed to the LPLC-induced alterations in membrane currents, then reducing bath Cl­
(equimolar replacement with isethionate) should have predictable effects on the reversal 
potential of the LPLC-induced current. Figure 9 shows the effects of a 1 0-fold reduction in 
bath Cl- on the steady-state membrane currents from a representative myocyte in control and 
following exposure to 1 �M LPLC. While the current in LPLC continued to increase with 
time, reducing bath Cl- failed to shift the reversal potential of the LPLC-induced current 
(l1E,ev = 1 .4 ± 1 . 8  mY, p = 0.547, n = 3). Hence, Cl- does not contribute to the LPLC­
induced current. In view of the charge carriers available, this means that the LPLC-induced 
current is a poorly-selective cation current that appears to be permeable to K+ and Na+. 
Although divalent cations also might be permeable, ionic substitution experiments with 
divalent cations were not performed because complex interactions of these ions with 
membrane phospholipids (i.e., surface charge screening, membrane fluidity alterations) 
(Hille, 1 992; Gordon, Sauerheber, and Esgate, 1 978) would confound interpretation. 
Lanthanides Inhibited the LPLC-Induced Current. 
Among the ion channel types described in heart, cationic stretch-activated ion 
channels exhibit non-selective conductances and are permeable to Na+, K+, and Ca2+ but not 
to Cl' (Bustamante, Ruknudin and Sachs, 1 99 1 ;  Ruknudin, Sachs and Bustamante, 1 993; 
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Figure 9. The LPLC-induced current was insensitive to a reduction in [Cl"]o. Following the increased inward current 
observed at the holding potential (-83 mV) in 1 IJM LPLC, bath [Cl"]o was reduced 1 0-fold (from 1 50 to 1 5  mM; 
equimolar replacement with isethionate). (A) Raw currents in control and during exposure to LPLC in normal and low 
[Cl"]o. (B) While the current continued to increase with time in LPLC, lowering [Cl"]o failed to shift the reversal 
potential of the LPLC·induced current (L':.Erev = 1 .4 ± 1 .8 mV, p = 0.55 , n = 3).  
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Kim, 1 993). Unlike voltage-dependent ion channels, stretch-activated channels are regulated 
by mechanical deformation (Yang and Sachs, 1 989; Ruknudin et al., 1993) or changes in 
cardiac cell volume (Suleymanian, Clemo, Cohen and Baumgarten, 1995; Clemo and 
Baumgarten, 1 997). Recent preliminary studies have shown that cardiac cell volume 
regulation is disrupted following exposure to micromolar concentrations of Iysolipids 
including LPLC (Suleymanian and Baumgarten, 1997). To investigate the possibility that 
cationic stretch-activated channels contributed to the LPLC-induced current, the effects of 
two lanthanides were studied. Although lanthanides at higher concentrations are nonspecific 
blockers of active transporters, exchangers and ion channels (for review, see Evans, 1 990), 
micromolar Gd3+ appears to be a selective and potent blocker of stretch-activated channels 
(Yang and Sachs, 1989; Cunningham, Wachtel and Abboud, 1 995). For instance, the open 
channel probability of the endogenous cationic stretch-activated channel in Xenopus oocytes 
was reduced by 4- orders of magnitude with 1 0  JlM Gdl+. On the other hand, greater than 
1 OOJlM La3+ was required to block these channels (Yang and Sachs, 1989). Figure 10 shows 
the dose-response relationship for Gd3+ inhibition of the LPLC-induced current. The data 
were well described by the Hill equation (Cornish-Bowden, 1 976) assuming complete 
blockade of the current and 1 :  1 binding stoichiometry. From the model, the concentration 
required for 50% inhibition (ICso) at -83 mV was 23.5 ± 5 . 1  JlM. Allowing the Hill 
coefficient to vary did not result in a significantly better fit to the data. The average 
inhibition achieved with 1 00 JlM La3+ (t.) also is shown. Since the LPLC-induced current 
increased with time, the percent-inhibition was based on the average LPLC-induced current 
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Figure 1 0. Dose-response relation for Gd3+ inhibition of the LPLC-induced current. 
Inhib ition of the LPLC-induced current was measured at -83 mV. The data were 
well described by the Hil l  equation (Y = 1 /( 1 + (X/ICso)n) with an ICso = 23.5 �M,  
assuming 1 : 1  binding. Allowing the Hi l l  coefficient (n)  to vary d id not result in a 
statistically better fit to the data. Since the current in LPLC continued to increase 
with time, percent inhibition was based on the average LPLC-induced current before 
and after lanthanide exposure. Summary data for inhibition achieved with 1 00 �M 
La3+(L!.) is also shown. 
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at -83 m V before and after drug. 
Figure 1 1  shows the effect of both lanthanides on the LPLC-induced current from 
representative cells. On average, 100 11M Gd3+ inhibited the LPLC-induced current by 80.2 
± 9.9 % at -83 mV (n = 7). Inhibition by 100 11M La3+ was indistinguishable from that 
achieved with equimolar Gd3+ (% inhibition = 80.7 ± 8.3, n = 6). The lack of selectivity 
between La3+ and Gd3+ and the lower than expected potency of Gd3+ suggested that stretch­
activated channels were not responsible for the LPLC-induced current. 
Confirmation that LPLC was not acting through stretch-activated ion channels was 
obtained from independent studies in which myocytes were shrunken osmotically (relative 
osmolarity = 1 .5; 1 50 mM mannitol added to the bath solution) following membrane 
depolarization in LPLC. The effect of hypertonicity on a representative myocyte exposed 
to 5 11M LPLC is shown in Figure 12A. Following depolarization in LPLC, switching the 
bathing media to hypertonic solution in the presence ofLPLC failed to inhibit the current (n 
= 2). In contrast, the current continued to increase with time until loss of myocyte viability. 
In similar experiments, switching to hypertonic bathing media following depolarization in 
LPLC also failed to recover the well-polarized resting potential (n = 5). 
When the LPLC-induced conductance was obtained by subtracting the current­
voltage relation in control isotonic bathing medium from that in LPLC under hypertonic 
conditions, it exhibited a pronounced outwardly rectifying component at negative potentials 
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Figure 1 1. Lanthanides (Gd3+ and La3+) consistently blocked the LPLC-induced current positive to the normal resting 
potential. However, the extent of blockade was variable at more negative potentials. (A) Gd3+ (100 IJM) inhibited 80.2 
± 8.3% (n=7) of the LPLC-induced current at -83 mY. B) La3+ ( 1 00 IJM) inhibited 80.7 ± 8.3% (n=6) of the LPLC­
induced current at -83 mV and was indistinguishable from the inhibition achieved with equimolar Gd3+. 
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Figure 12. Hypertonicity does not block the LPLC-induced current. To confirm that lanthanides were not inhibiting 
the LPLC-induced current by blocking stretch-activated channels, stretch-activated channels were inhibited by cell 
shrinkage in hypertonic bathing medium (relative osmolarity = 1 .5). A) I-V relationships under control, 5 �M LPLC, and 
LPLC: Hypertonic conditions. 8) Neither the LPLC-induced current (e)(n = 2) or membrane depolarization (n = 5, not 
shown)were inhibited by hypertonicity (.). Subtracting the I-V relationship under hypertonic from that under control 
isosmotic conditions (0) revealed an inwardly rectifying current characteristic of cation-selective stretch activated ion 
. channels. Their inhibition by hypertonic media explains the outward-going rectification at negative potentials observed 
in (.) . 
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negative to -80 mV (Figure 1 2B, .). However, subtracting the hypertonic control current-
voltage relation from that in LPLC under hypertonic conditions revealed a more linear 
LPLC-induced conductance (Figure 1 2B, "'). This rectification was attributed to basal 
stretch-activated channel activity associated with the conventional whole-cell recording 
configuration (Worrell, Butt, Cliff and Frizzell, 1989; Sorota, 1 992). The control stretch­
activated conductance exhibited inward rectification and is shown in Figure 12B (D). Basal 
stretch-activated channel activity did not influence the results. 
Lanthanides Delay Spontaneous Activity. 
Consistent with electrophysiological studies, pretreatment of myocytes with 100 IlM 
Gd3+ or La3+ significantly delayed the median time to development of spontaneous activity 
in 5 IlM LPLC (Figure 1 3). However, pharmacological blockade of Ca-channels with 1 00 
IlM Cd2+ failed to delay spontaneous activity in LPLC. Although spontaneous activity was 
not completely inhibited with Gd3+ or La3+ pretreatment at the concentration utilized, neither 
was the LPLC-induced current. Recalling that the average inhibition of the LPLC-induced 
current obtained with either lanthanide was �80% (Figure 1 1 ), the unblocked residual current 
may have contributed to the delayed time of spontaneous activity with LPLC. The 75th 
percentile for spontaneous activity in Gd3+ or La3+ is not shown in the figure because it was 
greater than the 60 min endpoint. 
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Figure 1 3. Consistent with patch clamp studies, pretreatment with 1 00 IJM La3+ or 
Gd3+, but not Cd2+, delayed the development of spontaneous activity in 5 IJM LPLC. 
Times for 25, 50, and 75% of myocytes to develop spontaneous activity are plotted. 
Median times were 1 6.4 min (n=36) for LPLC alone, and 1 7.4 (n= 1 9) ,  53.0 (n=38), 
and 55.4 min (n=35) for cells treated with LPLC +Cd2+, +La3+, and +Gd3+, 
respectively. The 75th percentile (not shown) was >60 min for both lanthanides. 
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Effects of LP Le on the Ventricular Action Potential. 
The LPLC-induced alterations in membrane current were predicted to have profound 
effects on cellular cardiac electrical activity. In vivo, myocardial ischemia has been reported 
to cause a reduction in the magnitude of the resting membrane potential, a shortening of 
action potential duration, a reduction in the rate of the Na-dependent upstroke (dV/dt), and 
finally, inexcitability (Downar et al. , 1977). To determine if LPLC produced similar effects 
to in vivo ischemia, action potentials were recorded from myocytes stimulated with 0.7 to 
1 .4 nA depolarizing current pulses, 3-5 ms in duration, at 0.5 Hz in the current-clamp 
configuration. Figure 14 shows representative action potential recordings from two different 
cells in control conditions and following brief exposure to 1 f!M LPLC. In control myocytes, 
the resting membrane potential was -82.1 ± 0.7 mV (n = 7), and action potential duration, 
measured from the time of the maximum upstroke to 90% repolarization (APD90), was 3 19.2 
± 1 9.2 ms (n = 7). After switching to bathing media supplemented with 1 f!M LPLC, APD90 
increased to 505.0 ± 32.5 ms, (n = 7) when measured just prior to induction of the sustained 
depolarization described earlier (see Figure 4). An 5.8 mV reduction in the action potential 
amplitude (from 128.3 to 1 22.5 mY, P = 0.009; n = 7), chiefly the result a modest 
depolarization of the resting membrane potential (from -82.5 to -78.3 mY, P = 0.0 1 ;  n = 7), 
also was observed. Subsequently, the resting potential underwent an abrupt and sustained 
depolarization to -22.3 ± 1 .6 mV (n = 7, P < 0.001) as shown earlier (Figure 4). Membrane 
depolarization was accompanied by the loss of excitability in all 7 cells, although an 
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Figure 14. Effect of LPLC on ventricular action potentials. Action potentials were elicited by brief current pulses (0.7-
1 .4 nA) 3-5 ms in duration .  Under control conditions, the resting membrane potential was stable and well polarized 
(-82. 1  ± 0.7 mY, n = 7) and the APDgo averaged 31 9.2 ± 1 9.3 ms (n = 7). Within 3-5 min of exposure to LPLC, in itial 
changes in the ventricular action potential were noted·(middle panel). These alterations included an increase in APDgo 
(505.0 ± 32.5 ms), a reduction in amplitude (from 1 28.3 ± 1 .4 to 1 22.5 ± 1 .6 mV), which could be accounted for by a 
4.2 mV depolarization of the resting membrane potential. Longer exposure to LPLC resulted in a massive and 
sustained depolarization to -22.3 ± 1 .6 mV concomitant with loss of excitabil ity. However, in some cases, a Ca2+­
dependent upstroke could be observed from a depolarized potential (see lower middle panel - ). In 2 out of 6 
myocytes, the effects of LPLC were reversible (washout). 
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occasional Ca-dependent upstroke was elicited (Figure 14, mid-lower panel). As a result, 
changes in dV/dt following exposure to LPLC could not be evaluated. Nevertheless, the 
LPLC-induced depolarization of the resting membrane potential and inexcitability are 
consistent with the effects seen in vivo during myocardial ischemia, although changes in 
APD90 were dissimilar (Downar et al., 1977). In 2 of 7 cells, the effect of LPLC on the 
ventricular action potential was reversible, and after washout, APD90 appeared to be shorter 
than under control conditions. 
Chapter 4 - Discussion 
Summary. 
The present study is the first to characterize the effects ofLPLC on cardiac myocytes. 
At the lowest concentrations investigated, 2.5 and 5 �M, LPLC induced spontaneous activity 
in rabbit ventricular myocytes significantly faster than the corresponding doses of LPC. 
Electrophysiological recordings revealed that LPLC induced a sustained depolarization of 
the resting membrane potential that was dose- and temperature-dependent. This 
depolarization was caused by the activation of a non-selective cationic current. The reversal 
potential of the LPLC-induced current was sensitive to a reduction in bath Na+ but was 
unaffected by Na-channel blockade with the guanidinium toxins TTX and STX. Ca-channeJ 
blockade with Cd2+ and experiments under low bath Cl- conditions also failed to affect the 
reversal potential of the LPLC-induced current indicating that neither a Ca-conductance from 
voltage dependent Ca-channels nor a Cl- conductance contributed to the LPLC-induced 
current. Poorly selective cationic stretch-activated channels were not responsible for the 
LPLC-induced current. At 100 �M, the lanthanides Gd3+ and La3+ were equally effective at 
inhibiting the LPLC-induced conductance, although Gd3+ is more potent than La3+ as a 
blocker of stretch-activated channels. The reversal potential of the LPLC-induced current 
was unaffected by cell shrinkage in hypertonic medium confirming that stretch activated 
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channels did not mediate the LPLC-induced current. 
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Consistent with the 
electrophysiological studies, pretreating myocytes with Gd3+ or La3+, but not Cd2+, 
significantly delayed the median time for development of spontaneous contractions in LPLC. 
Therefore, lanthanide inhibition of the LPLC-induced effects must occur through a 
mechanism that is independent of Ca-channel blockade. 
LPLC exerted profound effects on the ventricular action potential that were consistent 
with the LPLC-induced alterations of steady-state membrane currents. The initial slowing 
and, later, complete failure of action potential repolarization resulting in a sustained 
membrane depolarization were attributed to the time- and voltage-independent current 
induced by LPLC. Prolonged or complete loss of ventricular repolarization, as observed 
with LPLC, is a progenitor to severe forms of ventricular dysrhythrnias (El-Sherif, Zeiler, 
Craelius, Gough and Henkin, 1988; Janse, 1992; Roden, George and Bennett, 1 995). 
Consequently, accumulation ofLPLC in the sarcolemma of cardiac myocytes may contribute 
to life-threatening electrophysiological disturbances during myocardial ischemia. 
LPLC is Arrhythmogenic. 
LPC, the most extensively studied lysolipid, has been shown to affect a number of 
different ion channels and transport processes (see Table 1 ;  Corr, et al., 1 995). However, it 
is not known if these effects are a direct result of the lysolipid's  interaction with individual 
proteins or secondarily a result of changes in the biophysical properties of the membrane. 
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That Iysolipids directly affect bulk membrane properties is evident by a reduction in the 
order parameter (i.e., increased fluidity) and increased angular velocity of spin-labeled 
probes (Fink and Gross, 1 984). Since the function of integral membrane proteins depends 
on their annular lipid environment, Iysolipid-induced changes in membrane molecular 
dynamics may have important effects on protein function. Alternatively, alterations in 
membrane biophysical properties per se may disrupt membrane integrity and lead to loss of 
the permeability barrier (O'Regan et al. , 1996). 
At the lowest concentrations utilized in this study, LPLC induced spontaneous 
contractions in ventricular myocytes significantly faster than the corresponding doses of 
LPC. Although the mechanism responsible for these differences is unknown, several 
possibilities exist. In both model and biomembranes, ether-linked (i.e., Iysoplasmalogens) 
phospholipids are substantially more potent than LPC in their ability to disrupt phospholipid 
molecular dynamics (Fink and Gross, 1984; Han and Gross, 1 991). As indicated earlier, 
Iysophospholipid-induced changes in membrane molecular dynamics can affect protein 
function and may lead to Ca-overload and spontaneous contractions. Alternatively, increases 
in membrane fluidity per se may have been responsible for the shorter times to development 
of spontaneous contractions observed in LPLC. Changes in membrane permeability to 
various solutes parallel the changes in membrane fluidity (Lande, Donovan, and Zeide1, 
1 995). Thus, LPLC-induced increases in membrane fluidity may have resulted in a 
nonspecific transmembrane flux of ions resulting from breakdown of the membrane 
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penneability barrier. Another possible reason for the greater potency of LPLC is that 
differences in the equilibrium membrane partition coefficients or the kinetics of partitioning 
of LPLC as compared to LPC may have resulted in augmented sarcolemmal LPLC 
accumulation. Although data comparing the partition coefficients of these lysolipids could 
not be found, the vinyl-ether linkage in LPLC is expected to be more lipophilic compared 
to the acyl ester linkage ofLPC. Alternatively, differences in lysolipid catabolic rates could 
be responsible for the shorter times to development of spontaneous contractions in LPLC. 
Catabolism of LPC exceeds production by nearly 100-fold under normal conditions (Corr 
et al, 1 995). However, catabolism of LPLC is substantially slower than that of LPC and 
requires distinct enzyme isoforms (Gross, 1 992). This means LPC levels should remain low, 
even if the amphiphiles synthesis rate is increased. Thus, equimolar bath concentrations of 
lysolipids could result in greater sarcolemmal LPLC levels due to the amphiphile's lower 
clearance rate. Finally, because synthetic LPLC is not commercially available, a natural 
product derived from bovine heart was utilized. Based on the analysis provided by the 
supplier, 99% of the product was choline lysophospholipid with ,; 20% phosphatidyIcholine 
as the starting lipid. Thus, a nominally 5 �M LPLC solution is expected to contain at least 
4 �M LPLC and less than 1 �M LPC. It is unlikely that LPC contamination of the natural 
LPLC product was responsible for the spontaneous activity observed since the median time 
to development of spontaneous activity in synthetic 2.5 �M LPC was > 60 min. However, 
because the experimental LPLC solutions contained a mixture of lysolipid subclasses, a 
synergistic action cannot be rigorously excluded. 
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[PIC Induces Membrane Depolarization. 
The LPLC-induced spontaneous activity was attributed to a sustained depolarization 
of the resting membrane potential. Tonic depolarization of the resting potential can lead to 
inactivation ofNa-channels, slow conduction velocity, and dispersion of refractoriness in 
cardiac tissue. All of these factors contribute to the generation of the reentrant ventricular 
arrhythmias (Janse, 1992) most commonly associated with myocardial ischemia (Pogwizd 
and Corr, 1987). 
The time to depolarization in LPLC was dose-dependent and could be described with 
a simple linear model used to estimate the kinetics of drug-receptor interactions: 
A = k"n[LPLC] + kolT 
where A is the "on-rate" constant in reciprocal seconds and is the inverse of the mean time 
to depolarization, k"n is the pseudo first-order drug association rate constant, [LPLC] is the 
LPLC concentration, and k,,1T, is the dissociation rate constant (for a discussion of the kinetics 
of drug-receptor interactions see, Snyders, Bennett, and Hondeghem, 1992). The fit to the 
data is shown in Figure 15 .  The parameters estimated from the fit were: kon = 6.79 X 1 0-4 
�M·IS·I, and kolT = - 1 .32 x 10.3 S·I. A negative k,,1T is impossible. However, because the 95% 
confidence interval for k,,1T included positive values (range -0.0057737 to 0.003 1418  S·I), this 
model cannot be rejected for this reason alone. 
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Figure 1 5. Kinetic parameter estimation from the dose-dependent time to 
depolarization data in LPLC. The inverse mean time to depolarization is plotted as 
a function of LPLC concentration. The data were described by a linear regression 
having a slope = 6.79 x 1 0-4 �M S-l and y-intercept = -1 .32 x 1 0-3 S-l . Although a 
negative y-intercept for this model is impossible, the 95% confidence interval for this 
parameter extended from -0.0057737 to 0.0031418  S-l . Alternatively, modification 
of the model to include a threshold LPLC concentration, and assuming the 
dissociation rate constant is negligible, not only allows a negative value for the y­
intercept, but provides an estimate of the bath LPLC concentration required for 
membrane depolarization. However, because of the limited data, one model cannot 
be rejected in favor of the other. (Minimum n = 3 for each data point). 
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Even though a positive and therefore meaningful value for koff is possible for the 
given model, other factors make it an unattractive and even unlikely model to describe the 
time to depolarization in LPLC. Assuming that LPLC requires incorporation into the 
membrane, only crude estimates of kon can be made. This is because the value of kon 
undoubtedly reflects the rate limiting step of a multistep process for the LPLC-induced 
depolarization. Based on a model for LPC-induced lysis of erythrocytes, at least four 
independent steps have been proposed (for review, see Weltzien, 1 979). These steps in 
sequence are: 1) adsorption oflysolipid to the cell surface, 2) penetration into the membrane, 
3) induction of changes in membrane molecular organization, and finally, 4) ion permeability 
changes. The time to depolarization in LPLC corresponds to the last step, although this step 
need not be rate limiting. The dissociation rate constant, koff, also cannot uniquely 
characterize a single process that describes the off-rate kinetics for LPLC, since the Iysolipid 
can be cleared by egress from the membrane or through enzymatic degradation. 
Additionally, the model is unlikely because the equation is based on a first-order exponential 
relaxation process. LPLC was not observed to cause membrane depolarization along an 
exponential time course. Rather, depolarization occurred abruptly. The model assumes a 
reversible process. In no case were the effects of LPLC on membrane potential reversible 
upon washout in control solution for unstimulated myocytes. Furthermore, only 1 in 5 cells 
showed reversible effects when the control bath solution was supplemented with albumin 
following membrane depolarization in LPLC. 
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Alternatively, a negative y-intercept may arise because there i s  a critical threshold of 
bath LPLC concentration required for depolarization. This is described by a modification 
of the simple linear model shown above: 
A = k"n[LPLC] + b 
where, A, kon, and [LPLC] are as defined above, and b is the modified y-intercept. The value 
of b is given by: 
where [LPLC]th"hld is the critical threshold bath concentration of LPLC required to induce 
membrane depolarization. At present, k"ff and [LPLC]thrshld cannot be determined separately. 
However, assuming k"ff = 0 (since the control resting membrane could not be restored 
following washout of LPLC), the lower limit of [LPLC]th'5hld can be obtained by rearranging 
equation above and solving for [LPLC] when A - 0 or: 
[LPLC]th"hld = -b/kon-
Using the parameters of the fit in Figure 15 ,  the predicted [LPLC]thrshld = 1 .94 )lM at 23 °C. 
The time to depolarization in LPLC also appeared to be temperature-dependent. At 
1 0 °C, 2.5 )lM LPLC induced depolarization similar in magnitude but significantly faster 
than at room temperature (- 23 °C). The effect of temperature on the time to depolarization 
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is likely to be a complex process. This is because of the temperature-dependence of 
catabolic enzyme activity (Rawn, 1 989), membrane molecular dynamics (Katz, 1 992), and 
Iysolipid incorporation into the membrane (Weltzien, 1979). Consequently, no additional 
experiments characterizing the temperature-dependence of the LPLC-induced membrane 
depolarization were carried out. 
Interestingly, the potency of LPC-induced lysis of human erythrocytes exhibits a 
similar temperature-dependence and the proposed mechanism for that model may be 
instructive for the current study (Weltzien, Arnold and Kalkoff, 1976). The higher potency 
ofLPC on erythrocytes at cooler temperatures was attributed to an increased sensitivity of 
red cell membranes toward LPC and can be explained in terms of the temperature­
dependence on membrane molecular dynamics. At temperatures below the melting 
temperature (Tm), homogeneous membranes adopt a highly ordered or "gel-like" 
conformation (Stryer, 1988b). Upon heating, the lipid undergoes a transition from gel (i.e., 
highly ordered and structurally rigid) to liquid-crystalline conformation (i.e., highly 
disordered, increased fluidity). T m for this phase transition depends on the fatty acid 
molecular size, degree of unsaturation, and lipid homogeneity. Because biological 
membranes are comprised of heterogenous lipids, they do not exhibit well defined T m's and 
are predominantly in the liquid-crystalline phase at physiological temperatures. 
Nevertheless, incorporation of a membrane perturbing Iysolipid into regions of a 
biomembrane possessing well-ordered gel-like characteristics at colder temperatures may 
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result in the loss of membrane integrity due to the restricted motion of annular phospholipids. 
Thus, a similar or identical mechanism may explain the temperature dependence of the 
LPLC-induced depolarization in ventricular myocytes. Alternatively, the temperature 
dependence of depolarization could arise from the temperature-dependent effects on cardiac 
electrophysiological properties including membrane resistance and ion channel kinetics 
(Baumgarten and Fozzard, 1992). 
Characterization a/the LPLC-Induced Current. 
The ionic current responsible for the LPLC-induced membrane depolarization was 
voltage- and time-independent and exhibited a non-selective conductance. Once induced, 
the current in the presence of LPLC increased rapidly with time, which precluded steady­
state conductance measurements. Following exposure to LPLC, induction of the current was 
associated with a rapid and irreversible decline of myocyte viability. 
Based on the change in reversal potential with ionic substitution, the LPLC-induced 
current was estimated to have a PN,IPK ratio of 0. 12. This estimate was based on the 
assumption that the LPLC-induced current was permeable only to the monovalent cations 
Na+ and K+. Limited support for this assumption stems from the inability to detect an effect 
of CI' on the reversal potential of the LPLC-induced current. Blockade of Ca-channels with 
Cd2+ also failed to affect the reversal potential. However, the permeability to divalent 
cations, independent of voltage-gated Ca-channels, was not explored. This was because 
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extracellular Ca2+ modulates membrane permeability (Baumgarten and Fozzard, 1 992) and 
fluidity (Gordon et aI., 1 978). As a result, changing the extracellular Ca2+ concentration 
during ion substitution experiments could exacerbate the effects of LPLC. Thus, if a Cd­
insensitive Ca-conductance existed, the PN.lPK ratio will have been overestimated. 
The LPLC-induced membrane depolarization and ionic current were insensitive to 
Na-channel blockade by TTX and STX. The present study differs from the reports of 
previous investigators evaluating the effects of LPC on unitary and macroscopic cardiac Na­
currents. Among other effects, LPC was found to delay Na-channel inactivation kinetics. 
However, these differences may be explained by species differences, or methodology. For 
instance, with the single channel studies, myocytes were preincubated in high concentrations 
ofLPC for up to 2 h in a nominally Ca2+-free bathing solution before study (Undrovinas et 
aI., 1992). On the other hand, the present study evaluated the acute effects (i.e., minutes of 
exposure) of LPLC in a physiological ionic solution. More recently, LPC was reported to 
induce a non-selective current in guinea pig ventricular myocytes (Magishi et aI., 1996). As 
in the present study, the LPC-induced current was Na-dependent and unaffected by changes 
in external Cl-. However, the LPC-induced current reversed near 0 mY, compared to " -20 
mV for LPLC, had a predicted PN,IPK ratio of 0.78 compared with 0 .12 for LPLC, and was 
insensitive to blockade by 1 5  �M Gd3+. Presently, the reason for these differences between 
the two lysolipids is unknown. LPC and LPLC are derived from discreet subclasses of 
phospholipids and may activate similar but distinct nonselective ion permeation pathways. 
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Alternatively, the Iysolipids may activate an identical permeation pathway and the disparities 
may represent methodological or species differences. It is unlikely that the current arises 
from an LPLC-induced sustained activation of multiple ion selective channels, since 
blockade of voltage-dependent Na- and Ca-channels failed to inhibit the LPLC-induced 
current. 
Although low micromolar Iysolipid concentrations have been shown to disrupt 
cardiac cell volume regulation (Suleymanian and Baumgarten, 1997), this disruption was not 
the result of an LPLC-induced activation of stretch activated ion channels. At I 00 �M, both 
La3+ and Gd3+ were equally effective at inhibiting the LPLC-induced current, but only Gd3+ 
inhibits stretch-activated ion channels at this concentration (Yang and Sachs, 1 989). 
Additional evidence against a role for stretch-activated channel involvement was: 1)  the ICso 
for Gd3+ blockade of the LPLC-induced conductance was nearly 14-fold higher compared 
with that required to block 50% of the stretch-activated current induced by hypotonic 
swelling (Clemo and Baumgarten, 1997) and 2) failure of hypertonic medium to affect the 
reversal potential of the LPLC-induced current. 
Although Gd3+ inhibited the LPLC-induced current in a dose-dependent fashion, a 
lanthanide-insensitive component may exist. This was because the observed maximal 
inhibition of the LPLC-induced current was 80%, and blockade of the current with 1 00 �M 
Gd3+ was indistinguishable from that achieved with 30 �M Gd3+. However, when a 
lanthanide insensitive component was taken into account it did not result in a statistically 
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better fit to the data. 
Proposed Mechanismfor Lanthanide Inhibition of the LPLC-Induced Current. 
Lanthanides are notorious for their non-selective effects. For instance, depending on 
concentration, La3+ displaces bound Ca from cell surface membranes, inhibits Na-Ca­
exchange and the Na-K-ATPase (for review, see Evans, 1 990). Both La3+ and Gd3+ inhibit 
voltage-gated Ca-channels (Nachshen, 1984; Lacampagne, Gannier, Argibay, Garnier and 
Le Guennec, 1994) and decrease membrane fluidity (Evans, 1990; Li, Zhang, Ni, Chen and 
Hwang, 1994). While Gd3+, La3+, and Cd2+ all share the ability to block voltage-gated Ca­
channels, only the lanthanides selectively inhibited the LPLC-induced current and delayed 
the median time to spontaneous activity development in LPLC. Thus, it is unlikely that 
lanthanides inhibited the LPLC-induced current through blockade of voltage-dependent Ca­
channels. Although the effects oflanthanides or LPLC on electrogenic Na-Ca -exchange and 
the Na-K-ATPase were not evaluated in the present study, lanthanides and lysolipids inhibit 
these transporters (Karli et al. , 1979; Owens et aI. , 1 982; Evans, 1990; Bersohn et al., 1991).  
Because lanthanides and lysolipids exert parallel effects on these transporters, antagonistic 
effects oflanthanides on the LPLC-induced alterations of these transporters is unlikely. 
The inhibitory effects of lanthanides in the present study may be explained by their 
ability to antagonize LPLC-induced increases in membrane fluidity. Electron spin resonance 
studies with labeled probes incorporated in model cell and biomembranes including heart 
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sarcolemma (Uyesaka, Kamino, Ogawa, Inouye and Machida, 1976; Gordon et al. , 1978; Li, 
Zhang et al. , 1994) have shown La3+ increases the phospholipid order parameter (S) (i.e., 
decreased fluidity). In contrast, lysolipids reduce S in both model and biomembranes (Fink 
and Gross, 1984; Han and Gross, 1991). Membrane fluidity correlates with permeability to 
various solutes (Lande et aI. , 1 995), and La3+, at concentrations comparable to those used in 
the present study, was maximally effective at reducing membrane fluidity in cardiac 
sarcolemma (Gordon et al, 1978). However, Uyesaka et al. ( 1 976) found that much higher 
La3+ concentrations (millimolar) were necessary to decrease membrane fluidity in 
synaptosomal membranes. The equilibrium constant �) for the reduction in synaptosomal 
membrane fluidity was 1 .2 mM (Uyesaka et aI., 1976) and exceeds the IC50 for Od3+ 
inhibition the LPLC-induced current by 5 1 -fold. Interestingly, a reduction in fluidity was 
also observed with 3 mM Cd2+, which suggests an alternative mechanism for lanthanide 
inhibition of the LPLC-induced alterations. However, it should be emphasized, the study by 
Uyesaka et al. (1 976) utilized millimolar La3+ and Cd2+, well above concentrations used in 
the present electrophysiological study. Both high and low affinity lanthanide binding sites 
have been described in biomembranes (see Table 6-3, Evans, 1990), and it is possible that 
Uyesaka et al. (1976) characterized a second, low affinity, La3+ binding site that also 
modulates membrane fluidity. Indeed, the lowest La3+ concentration reported in Uyesaka et 
al. ( 1976) was - 0.75 mM (see Figure 5, Uyesaka et al. , 1976), which is more than sufficient 
to saturate the higher affinity binding described by Gordon et al. (1978). An alternative 
explanation for the differences in lanthanide concentrations required to reduce membrane 
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fluidity in synaptosomal (Uyesaka et a!., 1 976) and cardiac membranes (Gordon et al., 1978) 
may result from the latter being more sensitive to lanthanide induced changes in membrane 
fluidity. 
Arguments Against Lysolipid-Induced Changes in Membrane Fluidity Being Responsible for 
Effects Observed on Ion Channel Function. 
Because lysolipids affect a number of protein-mediated processes, it is usually 
assumed that the nonspecific effects of lysolipids result from perturbation of membrane 
biophysical properties rather than specific interactions with membrane proteins (for review, 
see Corr et al., 1995). The function of a number of integral membrane proteins is modulated 
by the characteristics of annular phospholipids (Katz, 1 992, Ford and Hale, 1996), that is, 
the lipid moieties that surround and directly interact with the protein. Accumulation of 
lysolipids in the cell membrane might increase the fluidity of annular phospholipids and 
thereby affect protein function nonspecifically. Recently, however, the notion that increases 
in fluidity per se are responsible for lysolipid-induced alterations in membrane protein 
function has been scrutinized in both model systems and biomembranes. When gramicidin 
channels were studied in diphytanoylphosphatidylcholine bilayers, addition of 1 -4 �M 
lysophosphatidylcholine increased the number and dwell time of open channel events 
(Lundbaek and Andersen, 1994). These effects were associated with an increase in the 
equilibrium dimerization constant for gramicidin channel formation. Prolongation of 
channel open time implies stabilization of the conducting gramicidin dimer. This was 
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attributed to a lysolipid-induced reduction in membrane deformation energy necessary for 
dimerization. Lundbaek et al. (1 996) argued that the membrane deformation energy is 
affected by the geometric shape of the amphiphile (Lundbaek, Bim, Girshman, Hansen and 
Andersen, 1 996). For instance, because the surface area of the polar head group ofLPC is 
greater than that of its hydrophobic tail, LPC adopts a conical shape. The conical shape 
promotes curvature in the membrane bilayer and reduces the free energy necessary for 
gramicidin dimerization and results in stabilization of the channel open-state. It was argued 
that an increased membrane fluidity should have accelerated both association and 
dissociation rate constants with no overall change in the dimerization constant (Lundbaek 
and Andersen, 1 994). Thus, the detailed analysis of channel kinetics was inconsistent with 
simple predictions for increase fluidity. Similar effects on the kinetics of gramicidin 
channels have been observed with other membrane perturbants (Lundbaek et al. , 1 996). 
Although it is unclear if lysolipid-induced reductions in membrane deformation 
energy can explain the effects of amphiphiles effects on ion channels, Lundbaek et al. ( 1996) 
suggested that the hyperpolarizing shift in the voltage-dependence of availability for N-type 
Ca-channels could fit such a model. However, the effects ofLPC on the voltage-dependence 
of cardiac Na-channel availability are dichotomous. Shander et al. ( 1 996) found LPC to 
cause a hyperpolarizing shift in the voltage-dependence of Na-channel availability. In 
contrast, Sato et al. (1 992) were unable to detect any effects of LPC on availability, yet 
palmitoylcarnitine, a zwitterionic structural analog ofLPC, caused a depolarizing shift in this 
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parameter. 
According to the Lundbaek et at. model (1 996), fatty acids should not influence the 
voltage-dependence of channel availability caused by changes in membrane deformation 
energy per se. This is because fatty acids adopt a cylindrical geometrical shape due to the 
similar surface areas of the polar head group and nonpolar tail. However, shifts in the 
voltage-dependence of ion channel availability have been reported with polyunsaturated fatty 
acids (Xiao, Kang, Morgan and Leaf, 1995). Still, other investigators were unable to detect 
any effect of both saturated and unsaturated long chain fatty acids (> 12 carbons) on the 
voltage-dependence of availability (Huang, Xian and Bacaner, 1992). Obviously, additional 
studies are needed to determine the precise role of amphiphiles (including fatty acids and 
Iysolipids) in modulating membrane deformation energy and the voltage-dependence of 
channel availability. 
Whereas the structural geometry of LPLC is expected to be similar to that of LPC, 
the effects of LPLC on membrane deformation energy have not been evaluated. 
Furthermore, the physiological role, if any, of changes in membrane deformation energy 
remain to be elucidated. Also, it remains unclear if LPLC modulates a particular ion channel 
or if the effect of LPLC results from nonspecific changes in membrane molecular dynamics 
(Han and Gross, 1991). In favor of the later possibility, is the fact that no identified ion 
channel has the spectrum of properties of the LPLC-induced channel. 
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Effects of LPLC on the Ventricular Action Potential. 
Consistent with effects reported for myocardial ischemia in vivo, LPLC decreased the 
action potential amplitude, and resting membrane potential. LPLC also increased the APD90• 
In contrast, both myocardial ischemia (Downar et al., 1977) or exogenous application of 
LPC shorten action potential duration (Sobel, COIT, Robison, Goldstein, Witkowski, and 
Klein, 1978; COIT, Snyder, Cain, Crafford Jr, Gross, and Sobel, 1981; Gross et al., 1982; Liu 
et al., 1991). However, the LPLC-induced prolongation of action potential duration is 
consistent with that expected for the non-selective current characterized under voltage clamp. 
Interestingly, exogenous application of LPC to isolated guinea pig ventricular myocytes 
caused shortening of action potential duration but induced a non-selective conductance (Liu 
et al. ,  1991) similar to that reported in the present study with LPLC. The characteristics of 
the LPC-induced conductance are inconsistent with the amphiphile's effect on action 
potential duration (Liu et al., 1991) suggesting disparate mechanisms are responsible for the 
shortening of action potential duration and induction of the non-selective current by LPC. 
Limitations of the Current Study. 
The current study explored the electrophysiological responses of single isolated 
ventricular myocytes to LPLC. Under the experimental conditions, both the extracellular and 
intracellular ionic milieu are controlled by the bath and pipette solutions respectively. 
However, during ischemia in vivo, the composition of these compartments undergo dramatic 
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changes including acidification of intracellular pH, a reduction in high energy phosphates 
(i.e., phosphocreatine, ATP), and changes in both the intra- and extracellular ionic 
composition (Gettes and Cascio, 1992). Thus, it is unlikely that the conditions of the present 
study mimic those in the setting of ischemia. However, if lysolipids contribute to life­
threatening arrhythmias during ischemia, results from the current study suggests that LPLC 
at least in part contributes to the electrophysiological sequella. 
This is the first documented study characterizing the electrophysiological effects of 
a lysolipid derived from plasmalogen phospholipids in rabbit cardiac myocytes. The present 
study evaluated whether inhibiting ion channels, and, in some instances pretreatment with 
blockers would reverse or prevent the effects of LPLC. It did not rigorously exclude the 
possibility that the detailed properties of individual ionic currents were modified by LPLC. 
For instance, the patch clamp technique can be utilized to investigate the effect of LPLC on 
Na-, Ca- and K-currents directly with appropriate voltage protocols and by using selective 
ion channel blockers in the bath and pipette solution to isolate the current under study. Such 
studies of the detailed properties of isolated currents were not undertaken because of time 
limitations. 
Once induced, the current in the presence ofLPLC could not be inhibited by Na-, Ca­
or stretch-activated-channel blockade, or by replacement of bath Cl· with isethionate. 
However, the experiments do not preclude the possibility that these channels may initiate the 
LPLC-induced depolarization. Limited evidence from the current study suggesting that Na-
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channels do not initiate the LPLC-induced membrane depolarization stems from experiments 
were myocytes were first pretreated with TTX prior to LPLC exposure. However, this 
maneuver failed to prevent or delay the time to spontaneous depolarization. Similarly, 
pretreating myocytes with Cd2+ also failed to delay the median time to spontaneous 
contractions in LPLC. 
The majority of experiments were performed at room temperature (23 °C), whereas 
others were carried out at 10 °C. LPLC is a labile amphiphile that is sensitive to oxidation. 
Although the electrophysiological effects of LPLC at physiological temperature is an 
important issue, the kinetics ofLPLC oxidation are likely increased at higher temperatures 
and may confound the results. Consequently, studies with LPLC above room temperature 
were not performed. 
Pathophysiological Implications for LPLC. 
Figure 16 shows a simplified scheme summarizing the biochemical manifestations 
of myocardial ischemia along with the electrophysiological results obtained with LPLC in 
the present study. LPLC is produced from the 40 kDa plasmalogen-selective PLA2 activated 
during ischemia (Ford et a!., 1991). LPLC elicited a current that was kinetically voltage- and 
time-independent, permeable to Na+ and K+, but not Cl', insensitive to pharmacological 
blockade of Na- and Ca-channels and inhibited by the lanthanides Gd3+ and La3+. The 
sustained influx ofNa+ would not only depolarize the cell membrane potential, but also lead 
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Figure 1 6 .  Biochemical manifestations of myocardial ischemia and the 
electrophysiological effects of LPLC. ( 1 )  One of the earliest manifestations of 
ischemia is a rise in the plasmalogen-selective Ca-independent PLA2 activity. LPLC 
is selectively liberated from this PLA2 and induces spontaneous contractions in 
ventricular myocytes significantly faster than LPC, an established proarrhythmic 
ischemic metabolite. (2) Spontaneous contractions were attributed to a sustained 
membrane depolarization caused by an LPLC-induced nonselective conductance. 
This conductance was sensitive to bath [Na+], but unaffected by a reduction in 
extracellular CI' or with Na- and Ca-channel blockade. (3) The sustained Na+ influx 
could lead to intracellular Na+ overload by slowing the rate of (4) Na-Ca-exchange 
and subsequently affect (5) intracellular Ca2+ homeostasis. Alternatively, Ca2+ influx 
may contribute directly to the LPLC-induced conductance. Because the non­
selective LPLC-induced conductance was insensitive to changes in bath [Cit K+ 
efflux likely contributes. An increased K+ efflux could contribute to elevated 
extracellular K+ levels observed within minutes of myocardial ischemia. 
Furthermore, elevated K+ would depolarize surrounding tissue resulting in slowed 
conduction and inexcitability. These are requisite components for reentrant 
ventricular arrhythmias. Arrhythmias could also result by lengthening the time of 
terminal repolarization observed with LPLC. The effects of LPLC on cardiac 
electrical activity may result from disruption of the membrane biophysical properties. 
The abil ity of the lanthanides Gd3+ and La3+ to increase phospholipid order and 
antagonize the effects of LPLC on ventricular myocytes is consistent with this 
hypothesis. 
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to augmented levels of intracellular Na+ with time. The increased intracellular Na + could 
indirectly affect internal Ca2+ homeostasis by slowing the rate of Na-Ca-exchange. 
Alternatively, Ca2+ may contribute directly to the LPLC-induced conductance. A subsequent 
rise in intracellular Ca2+ could exacerbate electrophysiologic and mechanical dysfunction 
during ischemia. Increases in extracellular K+ occur within minutes following myocardial 
ischemia (Gettes and Cascio, 1 992) and could arise in part from the current induced by 
LPLC. Accumulation of extracellular K+ would depolarize neighboring cells resulting in 
slowed conduction or loss of excitability. These electrical alterations are necessary for the 
establishment of reentrant ventricular arrhythmias (Janse, 1 992). Finally, prolongation of 
action potential duration as seen during exposure to LPLC is a predisposing factor to 
malignant ventricular dysrhythmias such as Torsade de pointes (El-Sherif et al, 1 988; Roden 
et al, 1 995). 
The effects of LPLC on cardiac myocytes described in the present study are 
consistent with the general membrane perturbing properties characteristic of all lysolipids. 
At sufficient concentrations, lysolipids form micelles that can have detergent-like effects on 
cell membranes. Although the critical concentration required for LPLC micelle formation 
under the conditions of the present study is unknown, the effects of lysolipids on membrane 
integrity can occur independently of micelle formation (Weltzien, 1 979; Fink and Gross, 
1984; O'Regan et al., 1 996). 
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Therapeutic Strategies. 
The current study has focused on the electrophysiological effects of LPLC and 
emphasizes the potential importance of subclass-specific phospholipid alterations during 
myocardial ischemia. A more thorough understanding of the biochemical pathways 
underlying plasmalogen metabolism may provide insights for the development of efficacious 
drugs that may reduce the high mortality associated with myocardial ischemia. Recently, 
attention has focused on the development of carnitine acyl transferase-I (CAT I) inhibitors 
for the treatment of ischemia-induced arrhythmias. These inhibit.ors work by inhibiting LPC 
and long-chain acyl carnitine accumulation in heart during early myocardial ischemia (Corr 
et ai. , 1 989). Long-chain acyl carnitines are structural analogs of LPC that inhibit key 
catabolic enzymes responsible for LPC degradation (for review, see, Yamada, Wu, Van and 
Corr, 1 993a). By inhibiting CAT I, acyl carnitines are not produced and thus cannot inhibit 
the enzymes necessary for LPC catabolism. 
Unfortunately, CAT I inhibitors are potentially double-edged swords. CAT I is 
necessary for shuttling fatty acids into the mitochondria for p-oxidation. Normally, between 
60-80% of the myocardial energy supply is derived from oxidation of fatty acids (McHowat 
et ai., 1 993). As a result, inhibition of transmitochondrial fatty acid flux results in the 
utilization of alternative sources for the fuel necessary for myocardial contraction. Indeed, 
inhibition of CAT I under aerobic conditions (non-ischemic protocol) resulted in a 2.S-fold 
increase in glucose oxidation (Sherratt, Gatley, DeGrado, Ng and Holden, 1 983). Although 
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CAT I inhibitors are beneficial in that they suppress arrhythmia and inhibit LPC 
accumulation within the first 5 minutes of myocardial ischemia (Corr, Creer, Yamada, 
Saffitz and Sobel, 1989), the longer term effects of CAT I inhibitors have not been reported. 
Lastly, reversible CAT I inhibitors are presently unavailable. As a consequence, 
mitochondrial metabolism may remain impaired long after the need for suppression of LPC 
accumulation has passed. 
Another potential strategy aimed at arrhythmia suppression during myocardial 
ischemia is the development of PLA2 inhibitors. Pretreatment with PLA2 inhibitors prior to 
induction of myocardial ischemia have been shown to limit the extent of membrane damage 
using a coronary occlusion model (Oinuma, Takamura, Hasegawa, Nomoto, Naitoh, Daiku, 
Hamano, Kakisawa and Minami, 1 990). In particular, selective irreversible inhibitors for the 
Ca-independent PLA2 have been shown to reduce the extent of damage resulting from 
hypoxia in cultured renal proximal tubules (Portilla, Mandel, 8ar-Sagi and Millington, 
1 992). This finding is promising, however the effects of plasmalogen selective PLA2 
inhibitors have not been reported for myocardial ischemia thus far. 
Subclass-Specific Phospholipid Alterations During Ischemia. 
Indirect evidence strongly suggests that Iysoplasmalogens increase during myocardial 
ischemia (for review, see Gross, 1 992). The majority of previous studies that have examined 
Iysolipid content following experimentally-induced myocardial ischemia have not looked for 
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LPLC (Shaikh and Downar, 1 98 1 ;  Steenbergen and Jennings, 1 984; Corr et ai, 1 989; 
Sargent, Vesterqvist, Ogletree, and Grover, 1993; Park, McHowat, Wolf, and Corr, 1 994) 
or have not distinguished LPLC content from diacyl lysolipid subclasses (Corr, Yamada, 
Creer, Sharma, and Sobel, 1 987). The few studies that have studied individual subclasses 
of lysolipids following ischemia must be considered with caution because of technical 
concerns (for example, see Vesterqvist, Sargent, Grover, Warrack, DiDonato and Ogletree, 
1 994). In rat, rabbit (Davies et a!., 1992), dog (Man, Slater, Pelletier and Choy, 1 983), and 
human (Sedlis et a!., 1 993), no increases in LPLC were found following 5 min to 24 h of 
myocardial ischemia. However, there are caveats in each of these studies. For instance, Man 
et a!. ( 1983), reported substantial experimental variability in lysoplasmalogen tissue content 
in both control and ischemic animals rendering the study insensitive. Sedlis et al. (1 993), 
reported that choline plasmalogen constituted 5% of total choline phospholipid in human 
myocardium, a value that is much lower than that reported by others (Horrocks and Sharma, 
1 982). Plasmalogens are extremely labile and may go undetected due to the conventional 
harsh intrapreparative techniques employed (Sedlis et al., 1993). Finally, in all these studies, 
lysoplasmalogen content was normalized relative to total myocardial phospholipid (Man et 
a!., 1 983; Davies et a!., 1 992; Sedlis et al., 1993). Since cardiac sarcolemma represents only 
about 2-8% of the total cellular cardiac phospholipid (Hazen and Gross, 1 992; Corr et al. , 
1 995), large increases in cardiac sarcolemmal lysoplasmalogen content could go undetected 
if they were offset by decreases in other membrane pools or if recovery of the phospholipid 
was affected by ischemia. 
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Although there is controversy regarding LPLC accumulation during myocardial 
ischemia, there is clear evidence in rabbit renal proximal tubules that brief hypoxia causes: 
1) an increase in the activity of a Ca-independent, and plasmalogen-selective PLA2 (Portilla 
et aI., 1 994); 2) the selective release of arachidonate from plasmalogen phospholipids 
(portilla and Creer, 1995); and 3) significant increases in tissue lysoplasmenylcholine content 
(Schonefeld et al., 1996). Clear answers to LPLC accumulation in ischemic heart will have 
to await more careful biochemical, subclass-specific analysis of sarcolemmal lysolipids. 
Membrane Incorporation of LP Le. 
The current study characterized the effects of exogenously applied LPLC. 
Accumulation of LPLC during ischemia could preferentially occur within the inner 
membrane leaflet. However, lysolipids can flip in biomembranes with much faster kinetics 
than those observed in synthetic bilayer experiments 01 an Besselaar, Kruijff, Van Den Bosch 
and Van Deenen, 1 979). Furthermore, there is evidence that flipping of lipids between 
leaflets may be facilitated by a protein-mediated process (Higgins, 1 994). However, even 
though LPLC may equally distribute between inner and outer membrane leaflets, 
intracellular application ofLPLC was not attempted with whole-cell patch clamp. The patch 
pipette represents a point source oflipid and access oflipid to distant sarcolemma is hindered 
by intracellular lipid binding proteins. As a result, intracellular application would result in 
a localized and highly nonuniform distribution of lysolipid. These problems may have 
contributed to the inability of some workers to detect any effect of intracellularly applied 
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LPC o n  transmembrane action potentials even at concentrations over 5-fold higher than those 
necessary to elicit changes with bath application (Akita, Creer, Yamada, Sobel and Corr, 
1 986). In contrast, palmitoyl camitine was equally effective from both sides of the 
membrane in eliciting a Na-dependent current (Wu and Corr, 1 994). These differences in 
response to intracellularly applied LPC and palmitoyl carnitine also may have resulted in part 
from the high capacity of lysophospholipase and acyl transferase to clear LPC from the 
cytosol. 
Conclusion. 
Previous studies investigating the arrhythmogenic effects of lysophospholipids have 
narrowly focused on lysophosphatidylcholine (LPC). While these studies have shown that 
LPC is a proarrhythmic ischemic metabolite, they have ignored the potential contribution of 
lysoplasmenylcholine (LPLC) to the electrophysiological sequella observed during 
myocardial ischemia. At the lowest concentrations investigated, LPLC induced spontaneous 
activity in ventricular myocytes significantly faster than LPC. Spontaneous activity 
observed in LPLC was attributed to membrane depolarization caused by induction of a 
nonselective cationic current. The current and spontaneous activity were inhibited with the 
lanthanides Gd3+ and La3+. Among other effects, lanthanides increase phospholipid order and 
may oppose increases in membrane fluidity believed responsible for the electrophysiological 
alterations due to LPLC. LPLC prolonged action potential duration and caused tonic 
depolarization of the resting membrane potential. Prolongation of the terminal repolarization 
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phase of the ventricular action potential is a progenitor to severe forms of ventricular 
arrhythmias. Furthermore, the sustained depolarization caused by LPLC can lead to slowed 
conduction, and dispersion of refractoriness, which are conducive to reentrant forms of 
arrhythmias. Consequently, sarcolemmal accumulation of LPLC may contribute to 
ventricular arrhythmias that ensue shortly following myocardial ischemia. 
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